<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving maternal and infant health - Spencer, L - 2015 | Cochrane Library</title> <meta content="Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving maternal and infant health - Spencer, L - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011263.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving maternal and infant health - Spencer, L - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011263.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011263.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving maternal and infant health" name="citation_title"/> <meta content="Laura Spencer" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="laura.spencer@adelaide.edu.au" name="citation_author_email"/> <meta content="Tanya Bubner" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="Emily Bain" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="Philippa Middleton" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD011263.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/09/21" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011263.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011263.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011263.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Infant Health; Hypothyroidism [diagnosis, therapy]; Mass Screening; Pre‐Eclampsia [diagnosis, therapy]; Preconception Care; Pregnancy Complications [*diagnosis, *therapy]; Randomized Controlled Trials as Topic; Thyroid Diseases [*diagnosis, *therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011263.pub2&amp;doi=10.1002/14651858.CD011263.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="nnwvukoo";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011263\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011263\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","ms","hr","fr","zh_HANT","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011263.pub2",title:"Screening and subsequent management for thyroid dysfunction pre\\u2010pregnancy and during pregnancy for improving maternal and infant health",firstPublishedDate:"Sep 21, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=nnwvukoo&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011263.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011263.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011263.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011263.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011263.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011263.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011263.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011263.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011263.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011263.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7102 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011263.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#CD011263-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#CD011263-sec-0154"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#CD011263-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#CD011263-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#CD011263-sec-0039"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#CD011263-sec-0040"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#CD011263-sec-0084"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#CD011263-sec-0148"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/table_n/CD011263StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/table_n/CD011263StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving maternal and infant health </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/information#CD011263-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Laura Spencer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/information#CD011263-cr-0003">Tanya Bubner</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/information#CD011263-cr-0004">Emily Bain</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011263.pub2/information#CD011263-cr-0005">Philippa Middleton</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/information/en#CD011263-sec-0160">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 21 September 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011263.pub2">https://doi.org/10.1002/14651858.CD011263.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011263-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011263-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011263-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011263-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011263-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011263-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011263-abs-0001" lang="en"> <section id="CD011263-sec-0001"> <h3 class="title" id="CD011263-sec-0001">Background</h3> <p>Thyroid dysfunction pre‐pregnancy and during pregnancy (both hyper‐ and hypothyroidism) is associated with increased risk of adverse outcomes for mothers and infants in the short‐ and long‐term. Managing the thyroid dysfunction (e.g. thyroxine for hypothyroidism, or antithyroid medication for hyperthyroidism) may improve outcomes. The best method of screening to identify and subsequently manage thyroid dysfunction pre‐pregnancy and during pregnancy is unknown. </p> </section> <section id="CD011263-sec-0002"> <h3 class="title" id="CD011263-sec-0002">Objectives</h3> <p>To assess the effects of different screening methods (and subsequent management) for thyroid dysfunction pre‐pregnancy and during pregnancy on maternal and infant outcomes. </p> </section> <section id="CD011263-sec-0003"> <h3 class="title" id="CD011263-sec-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (14 July 2015) and reference lists of retrieved studies. </p> </section> <section id="CD011263-sec-0004"> <h3 class="title" id="CD011263-sec-0004">Selection criteria</h3> <p>Randomised or quasi‐randomised controlled trials, comparing any screening method (e.g. tool, program, guideline/protocol) for detecting thyroid dysfunction (including hypothyroidism, hyperthyroidism, and/or thyroid autoimmunity) pre‐pregnancy or during pregnancy with no screening, or alternative screening methods. </p> </section> <section id="CD011263-sec-0005"> <h3 class="title" id="CD011263-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed eligibility of studies, extracted and checked data accuracy, and assessed the risk of bias of included studies. </p> </section> <section id="CD011263-sec-0006"> <h3 class="title" id="CD011263-sec-0006">Main results</h3> <p>We included two randomised controlled trials (involving 26,408 women) ‐ these trials were considered to be at low risk of bias. </p> <p><b>Universal screening (screening all women) versus case finding (screening only those at perceived increased risk) in pregnancy for thyroid dysfunction</b> </p> <p>One trial (4562 women) compared universal screening with case finding for thyroid dysfunction. Before 11 weeks' gestation, women in the universal screening group, and 'high‐risk' women in the case finding group had their sera tested for TSH (thyroid stimulating hormone), fT4 (free thyroxine) and TPO‐Ab (thyroid peroxidase antibody); women with hypothyroidism (TSH &gt; 2.5 mIU/litre) received levothyroxine; women with hyperthyroidism (undetectable TSH and elevated fT4) received antithyroid medication. </p> <p>In regards to this review's primary outcomes, compared with the case finding group, more women in the universal screening group were diagnosed with hypothyroidism (risk ratio (RR) 3.15, 95% confidence interval (CI) 1.91 to 5.20; 4562 women; GRADE: <i>high quality evidence</i> ), with a trend towards more women being diagnosed with hyperthyroidism (RR 4.50, 95% CI 0.97 to 20.82; 4562 women; P = 0.05; GRADE: <i>moderate quality evidence</i> ). No clear differences were seen in the risks of pre‐eclampsia (RR 0.87, 95% CI 0.64 to 1.18; 4516 women; GRADE: <i>moderate quality evidence</i> ), or preterm birth (RR 0.99, 95% CI 0.80 to 1.24; 4516 women; GRADE: <i>high quality evidence</i>) between groups. This trial did not report on neurosensory disability for the infant as a child. </p> <p>Considering this review's secondary outcomes, more women in the universal screening group received pharmacological treatment for thyroid dysfunction (RR 3.15, 95% CI 1.91 to 5.20; 4562 women). No clear differences between groups were observed for miscarriage (RR 0.90, 95% CI 0.68 to 1.19; 4516 women; GRADE: <i>moderate quality evidence</i> ), fetal and neonatal death (RR 0.92, 95% CI 0.42 to 2.02; 4516 infants; GRADE: <i>moderate quality evidence</i>), or other secondary outcomes: pregnancy‐induced hypertension, gestational diabetes, congestive heart failure, thyroid storm, mode of birth (caesarean section), preterm labour, placental abruption, respiratory distress syndrome, low birthweight, neonatal intensive care unit admission, or other congenital malformations. The trial did not report on a number of outcomes including adverse effects associated with the intervention. </p> <p><b>Universal screening versus no screening in pregnancy for hypothyroidism</b> </p> <p>One trial (21,846 women) compared universal screening with no screening for hypothyroidism. Before 15 + 6 weeks' gestation, women in the universal screening group had their sera tested; women who screened 'positive' (TSH &gt; 97.5th percentile, fT4 &lt; 2.5th percentile, or both) received levothyroxine. </p> <p>Considering primary review outcomes, compared with the no screening group, more women in the universal screening screened 'positive' for hypothyroidism (RR 998.18, 95% CI 62.36 to 15,978.48; 21,839 women; GRADE: <i>high quality evidence</i> ). No data were provided for the outcome pre‐eclampsia, and for preterm birth, the trial reported rates of 5.6% and 7.9% for the screening and no screening groups respectively (it was unclear if these percentages related to the entire cohort or women who screened positive). No clear difference was seen for neurosensory disability for the infant as a child (three‐year follow‐up IQ score &lt; 85) (RR 0.85, 95% CI 0.60 to 1.22; 794 infants; GRADE: <i>moderate quality evidence</i>). </p> <p>More women in the universal screening group received pharmacological treatment for thyroid dysfunction (RR 1102.90, 95% CI 69.07 to 17,610.46; 1050 women); 10% had their dose lowered because of low TSH, high fT4 or minor side effects. No clear differences were observed for other secondary outcomes, including developmental delay/intellectual impairment at three years. Most of our secondary outcomes, including miscarriage, fetal or neonatal death were not reported. </p> </section> <section id="CD011263-sec-0007"> <h3 class="title" id="CD011263-sec-0007">Authors' conclusions</h3> <p>Based on the existing evidence, though universal screening for thyroid dysfunction in pregnancy increases the number of women diagnosed with hypothyroidism who can be subsequently treated, it does not clearly impact (benefit or harm) maternal and infant outcomes. </p> <p>While universal screening versus case finding for thyroid dysfunction increased diagnosis and subsequent treatment, we found no clear differences for the primary outcomes: pre‐eclampsia or preterm birth. No clear differences were seen for secondary outcomes, including miscarriage and fetal or neonatal death; data were lacking for the primary outcome: neurosensory disability for the infant as a child, and for many secondary outcomes. Though universal screening versus no screening for hypothyroidism similarly increased diagnosis and subsequent treatment, no clear difference was seen for the primary outcome: neurosensory disability for the infant as a child (IQ &lt; 85 at three years); data were lacking for the other primary outcomes: pre‐eclampsia and preterm birth, and for the majority of secondary outcomes. </p> <p>For outcomes assessed using the GRADE approach the evidence was considered to be moderate or high quality, with any downgrading of the evidence based on the presence of wide confidence intervals crossing the line of no effect. </p> <p>More evidence is needed to assess the benefits or harms of different screening methods for thyroid dysfunction in pregnancy, on maternal, infant and child health outcomes. Future trials should assess impacts on use of health services and costs, and be adequately powered to evaluate the effects on short‐ and long‐term outcomes. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011263-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011263-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011263-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011263-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011263-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011263-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011263-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011263-abs-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD011263-abs-0011">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011263-abs-0005" lang="en"> <h3>Screening and subsequent treatment for thyroid dysfunction before or during pregnancy to improve outcomes for mothers and their babies </h3> <p><b>What is the issue?</b> </p> <p>What are the effects of different screening methods (for example screening all women versus screening only some women, or not screening women) for thyroid dysfunction before or during pregnancy on outcomes for the mother and her baby? </p> <p><b>Why is this important?</b> </p> <p>The thyroid is a large gland in the neck that produces hormones that help to regulate the chemical processes in the body that maintain life, including growth and energy use. If a woman has an overactive thyroid (hyperthyroidism), or an underactive thyroid (hypothyroidism) in pregnancy which is not managed, there is a possibility of poor outcomes for the mother and her baby. The mother may be more likely to develop high blood pressure and protein in the urine (pre‐eclampsia), give birth before 37 weeks of gestation (preterm birth), and her baby may develop disabilities (such as cerebral palsy, blindness, deafness and other developmental delays including intellectual impairment). Managing thyroid dysfunction in pregnancy (e.g. thyroxine for hypothyroidism, or antithyroid medication for hyperthyroidism) may improve outcomes for mothers and their babies. There are different methods of screening for thyroid dysfunction, including case finding, which means screening only pregnant women who are thought to be at high risk of thyroid dysfunction, or universal screening, which involves screening all pregnant women. Although universal screening may help to diagnose more women with hyperthyroidism or hypothyroidism than case finding, it could also lead to more women having medications and may be costly. It is not currently clear what the effects are of these different methods of screening for thyroid dysfunction for the mother and her baby, and health services. </p> <p><b>What evidence did we find?</b> </p> <p>In our search of the medical literature we found two randomised controlled trials, involving 26,408 women. The quality of the included trials was high, and the quality of the evidence they provided was moderate to high. </p> <p>(1) Universal screening for thyroid dysfunction in pregnancy, and hypothyroidism specifically, increased the number of women diagnosed with hypothyroidism, who were subsequently treated (one trial involving 4562 women; and one trial involving 21,839 women). The study of 4562 women also showed that there may have been an increase in the number of women diagnosed with hyperthyroidism with universal screening. </p> <p>(2) Universal screening and subsequent treatment did not show clear benefits or harms for the women or their babies as it did not change the number of women with pre‐eclampsia (in the one trial involving 4516 of 4562 women for this outcome), the number of women who gave birth preterm (one trial involving 4516 women), or the number of children with a disability (an intelligence quotient (IQ) less than 85 at three years of age) (one trial involving 794 children whose mothers had hypothyroidism from the total of 21,839 women). </p> <p>(3) One of the included trials did not report on later disabilities for the baby, and the other trial did not report on pre‐eclampsia or preterm birth. Neither of the trials reported on use of health services or costs. </p> <p><b>What does this mean?</b> </p> <p>Although the overall quality of the evidence was moderate to high, apart from finding that universal screening can help to diagnose more women with hypothyroidism (who may then be treated), there were no clear differences in outcomes for the mothers and their babies between universal screening and case finding (or not screening at all). Even though the two included studies involved a large number of women, further evidence is needed to assess the potential short‐ and long‐term benefits or harms of different screening methods, along with the impact on health services including costs. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011263-sec-0154" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011263-sec-0154"></div> <h3 class="title" id="CD011263-sec-0155">Implications for practice</h3> <section id="CD011263-sec-0155"> <p>Universal screening for thyroid dysfunction, or hypothyroidism specifically, in pregnancy increases the number of women diagnosed with hypothyroidism who can be subsequently treated, however impacts on maternal and infant outcomes are unclear. </p> <p>While universal screening versus case finding for thyroid dysfunction increased diagnosis and subsequent management, it did not lead to clear differences in the primary outcomes: pre‐eclampsia or preterm birth. No clear differences were seen for secondary outcomes, which included miscarriage and fetal or neonatal death; data were lacking for the primary outcome: neurosensory disability for the infant as a child, and for many secondary outcomes. Though universal screening versus no screening for hypothyroidism increased diagnosis and subsequent management, no clear difference was seen for the primary outcome: neurosensory disability for the infant as a child (IQ &lt; 85 at three‐year follow‐up), or secondary outcomes: developmental delay/intellectual impairment (CBCL and Brief‐P scores at three‐year follow‐up). Data were lacking for the other primary outcomes: pre‐eclampsia and preterm birth, and for the majority of secondary outcomes. </p> </section> <h3 class="title" id="CD011263-sec-0156">Implications for research</h3> <section id="CD011263-sec-0156"> <p>The results of this review show that universal screening for thyroid dysfunction is effective in identifying more women who can subsequently be treated. Data were lacking on some health outcomes, including many important short‐ and long‐term infant and child outcomes, and on impacts on use of health services and costs. Therefore, there is a need for further research to address these missing gaps in the evidence. One of the included trials in this review is currently undertaking further follow‐up of children (at seven to 10 years of age), to assess cognitive function. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011263-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011263-sec-0029"></div> <div class="table" id="CD011263-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Universal screening versus case finding in pregnancy for any thyroid dysfunction</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Universal screening versus case finding in pregnancy for any thyroid dysfunction</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women during pregnancy<br/> <b>Setting:</b> Italy<br/> <b>Intervention:</b> universal screening<br/> <b>Comparison:</b> case finding in pregnancy for any thyroid dysfunction </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with case finding in pregnancy for any thyroid dysfunction</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Universal screening</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Thyroid dysfunction diagnosed in pregnancy: hypothyroid</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.15<br/> (1.91 to 5.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4562<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/> (17 to 46) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Thyroid dysfunction diagnosed in pregnancy: hyperthyroid</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 4.50<br/> (0.97 to 20.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4562<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/> (1 to 18) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pre‐eclampsia</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.87<br/> (0.64 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4516<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000<br/> (24 to 44) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment, at latest time reported): IQ &lt; 85 at 3 years of age </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No data were available on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Preterm birth</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/> (0.80 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4516<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>66 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000<br/> (52 to 81) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.90<br/> (0.68 to 1.19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4516<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>45 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1000<br/> (31 to 54) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse effects associated with the intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No data were available on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Fetal and neonatal death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.92<br/> (0.42 to 2.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4516<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000<br/> (2 to 12) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Wide CI crossing the line of no effect (‐1) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011263-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Universal screening versus no screening in pregnancy for hypothyroidism</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Universal screening versus no screening in pregnancy for hypothyroidism</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women during pregnancy<br/> <b>Setting:</b> UK and Italy<br/> <b>Intervention:</b> universal screening<br/> <b>Comparison:</b> no screening in pregnancy for hypothyroidism </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no screening in pregnancy for hypothyroidism</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Universal screening</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Thyroid dysfunction diagnosed in pregnancy: hypothyroid</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 998.18<br/> (62.36 to 15978.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>21839<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thyroid dysfunction diagnosed in pregnancy: hyperthyroid</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="3" valign=""> <p>No data were available for these outcomes.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐eclampsia</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Preterm birth</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment, at latest time reported): IQ &lt; 85 at 3 years of age </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.85<br/> (0.60 to 1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>794<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>141 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>120 per 1000<br/> (85 to 172) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="3" valign="top"> <p>No data were available for these outcomes.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse effects associated with the intervention</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death (defined as all fetal and neonatal deaths)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Wide CI crossing the line of no effect (‐1) </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011263-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011263-sec-0030"></div> <section id="CD011263-sec-0031"> <h3 class="title" id="CD011263-sec-0031">Description of the condition</h3> <section id="CD011263-sec-0032"> <h4 class="title">Thyroid dysfunction in pregnancy</h4> <p>Thyroid dysfunction in pregnancy has been associated with a range of adverse maternal and fetal/infant outcomes, including miscarriage, pre‐eclampsia (high blood pressure and protein in the urine), preterm birth (birth before 37 weeks of gestation) and maternal thyroid dysfunction in the postpartum period (<a href="./references#CD011263-bbs2-0046" title="Stagnaro‐GreenA , AbalovichM , AlexanderE , AziziF , MestmanJ , NegroR , et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid2011;21(10):1081–125. ">Stagnaro‐Green 2011</a>). Questions have also been raised about increased risks of cognitive dysfunction and other adverse neurodevelopmental outcomes for children born to mothers with thyroid dysfunction during pregnancy (<a href="./references#CD011263-bbs2-0047" title="Stagnaro‐GreenA , PearceE . Thyroid disorders in pregnancy. Nature Reviews Endocrinology2012;8(11):650‐8. ">Stagnaro‐Green 2012</a>). Thyroid dysfunction in pregnancy may be categorised as: hypothyroidism (subclinical and overt), isolated hypothyroxinaemia, thyroid autoimmunity, and hyperthyroidism (including Graves' disease and gestational thyrotoxicosis) (<a href="./references#CD011263-bbs2-0035" title="NegroR , MestmanJ . Thyroid disease in pregnancy. Best Practice and Research Clinical Endocrinology and Metabolism2011;25(6):927‐43. ">Negro 2011a</a>). Debate continues surrounding the most appropriate strategies to identify and subsequently manage women with thyroid dysfunction before, during and after pregnancy, to prevent the potential adverse consequences. </p> <p>Normal pregnancy is associated with important and complex changes in maternal thyroid physiology and hormone production, and maternal and fetal thyroid hormone profiles change as gestation progresses. During the first trimester, normal thyroid function results in an increase in thyroxine (T4) and triiodothyronine (T3) production, and a subsequent inhibition of thyroid‐stimulating hormone (TSH), in part due to the production of high concentrations of human chorionic gonadotrophin (hCG) (a hormone produced in pregnancy), which stimulates the TSH receptor (<a href="./references#CD011263-bbs2-0030" title="KrajewskiDA , BurmanKD . Thyroid disorders in pregnancy. Metabolism Clinics of North America2011;40(4):739‐63. ">Krajewski 2011</a>). </p> <p>The relationship between maternal and fetal thyroid hormone production is particularly important during the first half of pregnancy. Thyroid hormone is critical for the early development and maturation of the fetal brain, and thus the maternal transfer of thyroid hormone is essential, especially during the first trimester (<a href="./references#CD011263-bbs2-0012" title="CooperDS , BiondiB . Subclinical thyroid disease. Lancet2012;379(9821):1142‐54. ">Cooper 2012</a>). The fetal thyroid gland does not begin to synthesise thyroid hormone until approximately 12 to 13 weeks' gestation and prior to this time any requirement for thyroid hormone is reliant on the mother (<a href="./references#CD011263-bbs2-0008" title="CaseyBM , LevenoKJ . Thyroid disease in pregnancy. Obstetrics and Gynecology2006;108(5):1283‐92. ">Casey 2006</a>). </p> <p>Thyroid dysfunction during pregnancy, its associated adverse outcomes, as well as management strategies, have been widely researched over the last few decades; and clinical practice guidelines have been produced to assist health practitioners in the provision of appropriate care (<a href="./references#CD011263-bbs2-0013" title="DeGrootL , AbalovichM , AlexanderE , AminoN , BarbourL , CobinR , et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism2012;97(8):2543‐65. ">De Groot 2012</a>; <a href="./references#CD011263-bbs2-0046" title="Stagnaro‐GreenA , AbalovichM , AlexanderE , AziziF , MestmanJ , NegroR , et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid2011;21(10):1081–125. ">Stagnaro‐Green 2011</a>). Ongoing debate however, continues regarding the most effective way to identify women with thyroid dysfunction prior to and during pregnancy, and also women who may be at risk of developing thyroid dysfunction during pregnancy. </p> </section> <section id="CD011263-sec-0033"> <h4 class="title">Hypothyroidism</h4> <p>Overt hypothyroidism (OH) is characterised by an underactive thyroid gland, or symptomatic thyroid hormone deficiency, defined by low T4 and high TSH concentrations. The prevalence of overt hypothyroidism has been estimated between 0.2% and 1.0% (<a href="./references#CD011263-bbs2-0035" title="NegroR , MestmanJ . Thyroid disease in pregnancy. Best Practice and Research Clinical Endocrinology and Metabolism2011;25(6):927‐43. ">Negro 2011a</a>). Confirmation of hypothyroidism is achieved through measuring serum TSH. </p> <p>Globally, the most common causal factor for maternal hypothyroidism is iodine deficiency, with maternal iodine deficiency impairing the synthesis of maternal and fetal thyroid hormones. Iodine is an important substance for the thyroid gland to produce and secrete thyroid hormones (<a href="./references#CD011263-bbs2-0030" title="KrajewskiDA , BurmanKD . Thyroid disorders in pregnancy. Metabolism Clinics of North America2011;40(4):739‐63. ">Krajewski 2011</a>). Due to increased thyroid hormone production, increased renal excretion of iodine in addition to the iodine requirements of the fetus, iodine requirements for women during pregnancy are higher than for non‐pregnant women. The World Health Organization recommends an iodine intake of 250 micrograms per day to meet the increased demand during pregnancy. In high‐income countries where iodine deficiency is less common, autoimmune thyroiditis (or Hashimoto's disease) is a more common cause of maternal hypothyroidism (<a href="./references#CD011263-bbs2-0046" title="Stagnaro‐GreenA , AbalovichM , AlexanderE , AziziF , MestmanJ , NegroR , et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid2011;21(10):1081–125. ">Stagnaro‐Green 2011</a>). </p> <p>Untreated maternal OH may be associated with significant complications for a mother and her baby, including hypertension, pre‐eclampsia, miscarriage, placental abruption (a complication of pregnancy, where the placental lining separates from the uterus) and postpartum haemorrhage (loss of blood following birth). Fetal or infant complications associated with untreated maternal OH include preterm birth and low birthweight (<a href="./references#CD011263-bbs2-0047" title="Stagnaro‐GreenA , PearceE . Thyroid disorders in pregnancy. Nature Reviews Endocrinology2012;8(11):650‐8. ">Stagnaro‐Green 2012</a>). Deficiency of thyroid hormone during critical periods of development has the potential to damage the nervous system, and while specific effects are not certain, evidence has accumulated to suggest thyroid hormone deficiency might be one of the causes of cerebral palsy (<a href="./references#CD011263-bbs2-0027" title="HongT , PanethN . Maternal and infant thyroid disorders and cerebral palsy. Seminars in Perinatology2008;32(6):438‐45. ">Hong 2008</a>). A number of observational studies have linked maternal thyroid hormone concentrations in pregnancy with childhood neurodevelopmental outcomes; for example, in two studies, children born to mothers with untreated hypothyroidism during pregnancy, were shown to have significantly lower intelligence quotient (IQ) scores, when compared with control children (<a href="./references#CD011263-bbs2-0025" title="HaddowJE , PalomakiGE , AllanWC , WilliamsJR , KnightGJ , GagnonJ , et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New England Journal of Medicine1999;341(8):549‐55. ">Haddow 1999</a>; <a href="./references#CD011263-bbs2-0033" title="MitchellML , KleinRZ . The sequelae of untreated maternal hypothyroidism. European Journal of Endocrinology2004;151:45‐8. ">Mitchell 2004</a>). </p> <p>OH may be treated with levothyroxine, a thyroxine replacement, with the goal of maintaining a euthyroid state (thyroid hormones within a normal range) throughout the duration of pregnancy. Treatment is considered critical to reduce the complications associated with untreated disease, and while treatment has been consistently supported in clinical practice guidelines (<a href="./references#CD011263-bbs2-0013" title="DeGrootL , AbalovichM , AlexanderE , AminoN , BarbourL , CobinR , et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism2012;97(8):2543‐65. ">De Groot 2012</a>; <a href="./references#CD011263-bbs2-0046" title="Stagnaro‐GreenA , AbalovichM , AlexanderE , AziziF , MestmanJ , NegroR , et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid2011;21(10):1081–125. ">Stagnaro‐Green 2011</a>), the relevant Cochrane review (<i>Interventions for clinical and subclinical hypothyroidism pre‐pregnancy and during pregnancy</i>) recently highlighted the lack of randomised controlled trial evidence in this area (<a href="./references#CD011263-bbs2-0040" title="ReidSM , MiddletonP , CossichMC , CrowtherCA , BainE . Interventions for clinical and subclinical hypothyroidism pre‐pregnancy and during pregnancy. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD007752.pub3] ">Reid 2013</a>). </p> <p>Subclinical hypothyroidism (SH) refers to biological evidence of thyroid hormone deficiency in women who experience none, or very few clinical symptoms. SH is defined as a normal free T4 concentration with high TSH concentration. SH is considered to be the most common thyroid disorder to occur in pregnancy and the prevalence has been estimated between 1.5% and 4% (<a href="./references#CD011263-bbs2-0035" title="NegroR , MestmanJ . Thyroid disease in pregnancy. Best Practice and Research Clinical Endocrinology and Metabolism2011;25(6):927‐43. ">Negro 2011a</a>). </p> <p>SH during pregnancy has been associated with an increased incidence of adverse outcomes similar to those associated with OH, however, in contrast to OH, SH represents a less severe degree of thyroid dysfunction (<a href="./references#CD011263-bbs2-0012" title="CooperDS , BiondiB . Subclinical thyroid disease. Lancet2012;379(9821):1142‐54. ">Cooper 2012</a>). Studies have associated untreated maternal SH to early loss of pregnancy, increased rates of placental abruption and preterm birth (<a href="./references#CD011263-bbs2-0031" title="LeBeauS , MandelS . Thyroid disorders during pregnancy. Endocrinology and Metabolism Clinics of North America2006;35(1):117‐36. ">Le Beau 2006</a>). Pregnancy loss, or miscarriage, is often noted as one of the most common complications linked to SH. Data from a prospective cohort study by Benhadi and colleagues reported an increased risk of miscarriage, fetal death and neonatal death with increasing concentrations of TSH during pregnancy, even in healthy women with no overt thyroid disorder (<a href="./references#CD011263-bbs2-0007" title="BenhadiN , WiersingaW , ReitsmaJ , VrijkotteT , BonselG . Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. European Journal of Endocrinology2009;160(6):985‐91. ">Benhadi 2009</a>). </p> <p>Treatment of SH with levothyroxine is not universally accepted, with recommendations differing between professional organisations (<a href="./references#CD011263-bbs2-0047" title="Stagnaro‐GreenA , PearceE . Thyroid disorders in pregnancy. Nature Reviews Endocrinology2012;8(11):650‐8. ">Stagnaro‐Green 2012</a>), and no clear evidence to support treatment from the relevant Cochrane review (<a href="./references#CD011263-bbs2-0040" title="ReidSM , MiddletonP , CossichMC , CrowtherCA , BainE . Interventions for clinical and subclinical hypothyroidism pre‐pregnancy and during pregnancy. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD007752.pub3] ">Reid 2013</a>). </p> <p>Isolated hypothyroxinaemia (IH) during pregnancy is defined by the detection of low serum‐free thyroxine (FT4) with TSH concentration within the normal range. Data suggest wide variation in the incidence of IH due to global differences in maternal iodine intake and the reliability of diagnostic tools (<a href="./references#CD011263-bbs2-0035" title="NegroR , MestmanJ . Thyroid disease in pregnancy. Best Practice and Research Clinical Endocrinology and Metabolism2011;25(6):927‐43. ">Negro 2011a</a>). Several studies have demonstrated that IH, largely caused by iodine deficiency (<a href="./references#CD011263-bbs2-0034" title="Morreale de EscobarG , ObregonMJ , Escobar del ReyF . Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia?. Journal of Clinical Endocrinology and Metabolism2000;85:3975‐87. ">Morreale 2000</a>), like hypothyroidism, can be associated with negative effects on fetal brain development and thus neurodevelopmental outcomes; increased risks of cognitive, language and motor dysfunction, including cerebral palsy have been reported (<a href="./references#CD011263-bbs2-0027" title="HongT , PanethN . Maternal and infant thyroid disorders and cerebral palsy. Seminars in Perinatology2008;32(6):438‐45. ">Hong 2008</a>). For example, low maternal FT4 has been associated with an increased risk of impaired psychomotor development for children at 10‐month follow‐up (<a href="./references#CD011263-bbs2-0038" title="PopVJ , KuijpensJL , vanBaarAL , VerkerkG , vanSonMM , deVijlderJJ , et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clinical Endocrinology1999;50(2):149‐55. ">Pop 1999</a>) and delayed mental and motor function at 12 and 24 months (<a href="./references#CD011263-bbs2-0039" title="PopVJ , BrouwersEP , VaderHL , VulsmaT , vanBaarAL , deVijlderJJ . Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3‐year follow‐up study. Clinical Endocrinology2003;59(3):282‐8. ">Pop 2003</a>); increased risks of impaired motor and intellectual development at 25 to 30 months (<a href="./references#CD011263-bbs2-0032" title="LiY , ShanZ , TengW , YuX , LiY , FanC , et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25‐30 months. Clinical Endocrinology2010;72(6):825‐9. ">Li 2010</a>); and expressive language delay and nonverbal cognitive delay at 18‐ to 30‐month follow‐up have also been reported (<a href="./references#CD011263-bbs2-0020" title="GhassabianA , HenrichsJ , TiemeierH . Impact of mild thyroid hormone deficiency in pregnancy on cognitive function in children: lessons from the Generation R study. Best Practice and Research Clinical Endocrinology and Metabolism2014;28(2):221‐32. ">Ghassabian 2014</a>). </p> </section> <section id="CD011263-sec-0034"> <h4 class="title">Thyroid autoimmunity</h4> <p>Maternal thyroid autoimmunity refers to the detection of thyroid antibodies against thyroperoxidase (TPO‐Ab) and/or thyroglobulin (Tg‐Ab) in combination with normal thyroid function. The estimated incidence of thyroid autoimmunity in women of reproductive age has been reported to be between 8% and 14% (<a href="./references#CD011263-bbs2-0053" title="VissenbergR , van denBoogaardE , vanWelyM , van derPostJA , FliersE , BisschopPH , et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Human Reproduction Update2012;18(4):360‐73. ">Vissenberg 2012</a>). The precise mechanisms that underpin thyroid autoimmunity are not known, however it has been hypothesised that the presence of antibodies are part of an undefined autoimmune response, or that they may reflect a subtle reduction in optimum thyroid function (<a href="./references#CD011263-bbs2-0036" title="NegroR , Stagnaro‐GreenA . Thyroid autoantibodies, preterm birth and miscarriage. BMJ2011;342:d2260. ">Negro 2011b</a>). Thyroid autoimmunity has been associated with an increased risk of the development of maternal hypothyroidism during pregnancy (<a href="./references#CD011263-bbs2-0052" title="van denBoogaardE , VissenbergR , LandJA , vanWelyM , van derPostJA , GoddijnM , et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Human Reproduction Update2011;17(5):605‐19. ">van den Boogaard 2011</a>), and postpartum thyroid dysfunction (<a href="./references#CD011263-bbs2-0046" title="Stagnaro‐GreenA , AbalovichM , AlexanderE , AziziF , MestmanJ , NegroR , et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid2011;21(10):1081–125. ">Stagnaro‐Green 2011</a>). The detection of thyroid antibodies in the early stages of pregnancy confers a 33% to 50% chance of the woman developing postpartum thyroiditis (<a href="./references#CD011263-bbs2-0045" title="Stagnaro‐GreenA . Postpartum thyroiditis. Best Practice and Research Clinical Endocrinology and Metabolism2004;18(2):303‐16. ">Stagnaro‐Green 2004</a>). Women with thyroid antibodies during pregnancy who recover from postpartum thyroiditis experience a 70% recurrence rate in future pregnancies, and additionally, are at a significantly higher risk of developing permanent hypothyroidism (<a href="./references#CD011263-bbs2-0042" title="SamuelsMH . Subacute, silent, and postpartum thyroiditis. Medical Clinics of North America2012;96:223‐33. ">Samuels 2012</a>). </p> <p>Thyroid autoimmunity during pregnancy has been associated with poor fertility outcomes, recurrent miscarriage and preterm birth (<a href="./references#CD011263-bbs2-0049" title="ThangaratinamS , TanA , KnoxE , KilbyMD , FranklynJ , CoomarasamyA . Association between thyroid autoantibodies and miscarriage and preterm birth: meta‐analysis of evidence. BMJ2011;342:d2616. ">Thangaratinam 2011</a>; <a href="./references#CD011263-bbs2-0052" title="van denBoogaardE , VissenbergR , LandJA , vanWelyM , van derPostJA , GoddijnM , et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Human Reproduction Update2011;17(5):605‐19. ">van den Boogaard 2011</a>). Thyroid autoimmunity in combination with high TSH concentrations early in gestation has also been associated with a four‐fold increased risk of gestational diabetes for the mother (<a href="./references#CD011263-bbs2-0029" title="KarakostaP , AlegakisD , GeorgiouV , RoumeliotakiT , FthenouE , VassilakiM , et al. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. Journal of Clinical Endocrinology and Metabolism2012;97(12):4464‐72. ">Karakosta 2012</a>). For women with insulin dependent diabetes mellitus, the presence of TPO‐Ab prior to pregnancy has been suggested to confer an increased risk of poorer glucose control and an increased risk of developing hypothyroidism (<a href="./references#CD011263-bbs2-0016" title="Fernandez‐SotoL , GonzalezA , LobónJA , LopezJA , PetersonCM , Escobar‐JiménezF . Thyroid peroxidase autoantibodies predict poor metabolic control and need for thyroid treatment in pregnant IDDM women. Diabetes Care1997;20(10):1524‐8. ">Fernandez‐Soto 1997</a>). While the exact relationships between the conditions are unclear, both thyroid autoimmunity and postpartum thyroiditis have been associated with depression (<a href="./references#CD011263-bbs2-0045" title="Stagnaro‐GreenA . Postpartum thyroiditis. Best Practice and Research Clinical Endocrinology and Metabolism2004;18(2):303‐16. ">Stagnaro‐Green 2004</a>). In a recent study, pregnant TPO‐Ab positive women were shown to have higher depressive symptoms during pregnancy, and higher depression, anger and total mood disturbance postpartum, regardless of the development of postpartum thyroiditis (<a href="./references#CD011263-bbs2-0024" title="GroerMW , VaughanJH . Positive thyroid peroxidase antibody titer is associated with dysphoric moods during pregnancy and postpartum. Journal of Obstetric, Gynecologic, and Neonatal Nursing2013;42:26‐32. ">Groer 2013</a>). </p> <p>Similar to risks for the child associated with hypothyroidism and hypothyroxinaemia, children born to mothers with thyroid autoimmunity have been shown to be at risk of adverse neurodevelopmental outcomes. Elevated concentrations of TPO‐Ab in women between 16 to 20 weeks of gestation have been shown to be a predictor of poor motor skills and intellectual development in early childhood (<a href="./references#CD011263-bbs2-0032" title="LiY , ShanZ , TengW , YuX , LiY , FanC , et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25‐30 months. Clinical Endocrinology2010;72(6):825‐9. ">Li 2010</a>). Maternal thyroid autoimmunity has also been associated with an increased risk of behavioural problems in childhood, particularly attention deficit and hyperactivity (<a href="./references#CD011263-bbs2-0019" title="GhassabianA , Bongers‐SchokkingJJ , deRijkeYB , vanMilN , JaddoeVW , deMuinck Keizer‐SchramaSM , et al. Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: the Generation R Study. Thyroid2012;22(2):178‐86. ">Ghassabian 2012</a>). </p> <p>Current clinical guidelines outline no specific treatment for women with detected thyroid autoantibodies, however encourage monitoring of serum TSH during pregnancy due to the increased risk of hypothyroidism (<a href="./references#CD011263-bbs2-0046" title="Stagnaro‐GreenA , AbalovichM , AlexanderE , AziziF , MestmanJ , NegroR , et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid2011;21(10):1081–125. ">Stagnaro‐Green 2011</a>). The relevant Cochrane review identified no significant difference for the outcome of pre‐eclampsia when levothyroxine treatment was compared with no treatment for women who were TPO‐Ab positive and euthyroid during pregnancy, however, noted a reduction in preterm birth and miscarriage with levothyroxine treatment (<a href="./references#CD011263-bbs2-0040" title="ReidSM , MiddletonP , CossichMC , CrowtherCA , BainE . Interventions for clinical and subclinical hypothyroidism pre‐pregnancy and during pregnancy. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD007752.pub3] ">Reid 2013</a>). The review emphasised that due to the small number of trials contributing data to the review, at a moderate risk of bias overall, there was insufficient evidence to make clear conclusions and to guide clinical practice. </p> </section> <section id="CD011263-sec-0035"> <h4 class="title">Hyperthyroidism</h4> <p>Hyperthyroidism is characterised by an overactive thyroid gland and the release of excessive amounts of thyroid hormones. Hyperthyroidism during pregnancy is rare with reported incidences ranging from 0.1% to 0.4%, and most women who experience the condition are diagnosed prior to conception and pregnancy (<a href="./references#CD011263-bbs2-0011" title="ChangD , PearceE . Screening for maternal thyroid dysfunction in pregnancy: a review of the clinical evidence and current guidelines. Journal of Thyroid Research2013;2013:851326. ">Chang 2013</a>). Causes of hyperthyroidism can be distinguished as immune or non‐immune in origin (<a href="./references#CD011263-bbs2-0035" title="NegroR , MestmanJ . Thyroid disease in pregnancy. Best Practice and Research Clinical Endocrinology and Metabolism2011;25(6):927‐43. ">Negro 2011a</a>), with the autoimmune condition Graves' disease accounting for an estimated 85% of cases (<a href="./references#CD011263-bbs2-0031" title="LeBeauS , MandelS . Thyroid disorders during pregnancy. Endocrinology and Metabolism Clinics of North America2006;35(1):117‐36. ">Le Beau 2006</a>). Graves' disease (in which autoantibodies stimulate the thyroid TSH receptor) is characterised by varied clinical presentation including heat intolerance, shortness of breath, the presence of a goitre, ophthalmopathy (swollen tissue behind the eyes), and rarely, thyroid storm (an acute, life‐threatening, hyper‐metabolic state induced by excessive release of thyroid hormones) and congestive heart failure. Uncontrolled hyperthyroidism as a result of Graves' disease has been associated with an increased risk of perinatal complications, including miscarriage, stillbirth, preterm birth, fetal growth restriction, and pre‐eclampsia (<a href="./references#CD011263-bbs2-0047" title="Stagnaro‐GreenA , PearceE . Thyroid disorders in pregnancy. Nature Reviews Endocrinology2012;8(11):650‐8. ">Stagnaro‐Green 2012</a>). Anti‐thyroid drugs (such as propylthiouracil and carbimazole) may be used to treat hyperthyroid women during pregnancy with the goal of achieving a euthyroid state (<a href="./references#CD011263-bbs2-0046" title="Stagnaro‐GreenA , AbalovichM , AlexanderE , AziziF , MestmanJ , NegroR , et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid2011;21(10):1081–125. ">Stagnaro‐Green 2011</a>). A recent Cochrane review (<i>Interventions for hyperthyroidism pre‐pregnancy and during pregnancy</i>) however found no completed randomised controlled trials for inclusion addressing management in this area (<a href="./references#CD011263-bbs2-0015" title="EarlR , CrowtherCA , MiddletonP . Interventions for hyperthyroidism pre‐pregnancy and during pregnancy. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD008633.pub2] ">Earl 2013</a>). </p> <p>The most common cause of non‐immune hyperthyroidism is gestational thyrotoxicosis, also referred to as transient gestational hyperthyroidism, caused by elevated concentrations of hCG beyond normal range in early pregnancy. Diagnosis is confirmed by suppressed or very low serum TSH concentrations in the presence of high T4 (<a href="./references#CD011263-bbs2-0035" title="NegroR , MestmanJ . Thyroid disease in pregnancy. Best Practice and Research Clinical Endocrinology and Metabolism2011;25(6):927‐43. ">Negro 2011a</a>). Gestational thyrotoxicosis is commonly associated with hyperemesis gravidarum (or severe morning sickness) and characterised by severe nausea, early‐onset vomiting, and dehydration during the first trimester of pregnancy. Gestational thyrotoxicosis has not been associated with poor obstetric or infant outcomes, however women affected during pregnancy may require hospitalisation for supportive treatment to manage dehydration and other symptoms (<a href="./references#CD011263-bbs2-0047" title="Stagnaro‐GreenA , PearceE . Thyroid disorders in pregnancy. Nature Reviews Endocrinology2012;8(11):650‐8. ">Stagnaro‐Green 2012</a>). Anti‐thyroid drugs have not been recommended, as serum T4 generally returns to normal concentrations between 14 and 18 weeks' gestation (<a href="./references#CD011263-bbs2-0046" title="Stagnaro‐GreenA , AbalovichM , AlexanderE , AziziF , MestmanJ , NegroR , et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid2011;21(10):1081–125. ">Stagnaro‐Green 2011</a>). </p> </section> </section> <section id="CD011263-sec-0036"> <h3 class="title" id="CD011263-sec-0036">Description of the intervention</h3> <p>Given the prevalence of thyroid disorders in pregnancy, the significance of the short‐ and long‐term adverse outcomes for both the mother and her baby, and the availability of potential management options (dependent on the type of disease and clinical scenario), the early identification of women with thyroid dysfunction prior to or during pregnancy is of great importance (<a href="./references#CD011263-bbs2-0035" title="NegroR , MestmanJ . Thyroid disease in pregnancy. Best Practice and Research Clinical Endocrinology and Metabolism2011;25(6):927‐43. ">Negro 2011a</a>; <a href="./references#CD011263-bbs2-0053" title="VissenbergR , van denBoogaardE , vanWelyM , van derPostJA , FliersE , BisschopPH , et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Human Reproduction Update2012;18(4):360‐73. ">Vissenberg 2012</a>). </p> <p>Screening is a strategy used to identify unrecognised disease in individuals; this can include those with pre‐symptomatic or unrecognised symptomatic disease. Screening interventions are designed to detect disease early, to enable earlier intervention and management with the ultimate aim of improving health outcomes (<a href="./references#CD011263-bbs2-0037" title="UK National Screening Committee. What is screening? UK Screening Portal. http://www.screening.nhs.uk/screening Accessed 20 November 2013. ">NSC 2013</a>). Currently, maternal thyroid disorders are largely detected based on clinical presentation of symptoms and further assessment of thyroid hormone concentrations. Potential screening tests for thyroid dysfunction during pregnancy (such as testing for serum TSH and/or the presence of TPO‐Ab) are readily accessible and the improved sensitivity of new generation assays allow for the detection of extremely low serum TSH concentrations, often seen in early pregnancy (<a href="./references#CD011263-bbs2-0022" title="GlinoerD , SpencerCA . Serum TSH determinations in pregnancy: how, when and why?. Nature Reviews. Endocrinology2010;6(9):526‐9. ">Glinoer 2010</a>). </p> <p>Current clinical practice guidelines differ in their recommendations for screening, however, generally advocate for a 'case finding' rather than a 'universal screening' approach (<a href="./references#CD011263-bbs2-0011" title="ChangD , PearceE . Screening for maternal thyroid dysfunction in pregnancy: a review of the clinical evidence and current guidelines. Journal of Thyroid Research2013;2013:851326. ">Chang 2013</a>). Universal screening involves screening all pregnant women, whereas case finding involves screening a smaller group of individuals of perceived increased risk. Case finding strategies can also differ, with some guidelines, such as those from the American College of Obstetrics and Gynaecology and from the United States Society for Maternal‐Fetal Medicine, recommending thyroid testing only in high‐risk pregnant women who are symptomatic, have a personal history of thyroid disorders, have type 1 diabetes or another autoimmune disorder (<a href="./references#CD011263-bbs2-0005" title="Committee on Patient Safety and Quality Improvement, Committee on Professional Liability. ACOG Committee Opinion No. 381: Subclinical hypothyroidism in pregnancy. Obstetrics and Gynecology2007;110(4):959‐60. ">ACOG 2007</a>; <a href="./references#CD011263-bbs2-0044" title="Society for Maternal‐Fetal Medicine (SMFM), Gyamfi‐BannermanC . Screening for thyroid disease during pregnancy. Contemporary Ob/Gyn2012;57(8):45‐7. ">SMFM 2012</a>). Other guidelines such as those of the American Association of Clinical Endocrinologists, American Thyroid Association, and Endocrine Society Task Force recommend a more 'aggressive' case finding approach (<a href="./references#CD011263-bbs2-0013" title="DeGrootL , AbalovichM , AlexanderE , AminoN , BarbourL , CobinR , et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism2012;97(8):2543‐65. ">De Groot 2012</a>; <a href="./references#CD011263-bbs2-0017" title="GarberJR , CobinRH , GharibH , HennesseyJV , KleinI , MechanickJI , et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocrine Practice2012;18(6):988‐1028. ">Garber 2012</a>; <a href="./references#CD011263-bbs2-0046" title="Stagnaro‐GreenA , AbalovichM , AlexanderE , AziziF , MestmanJ , NegroR , et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid2011;21(10):1081–125. ">Stagnaro‐Green 2011</a>), and provide detailed criteria for targeted thyroid disease case finding in newly pregnant women or women planning pregnancy (example criteria: over 30 years; family history of thyroid dysfunction; goitre; personal history of thyroid dysfunction; prior head/neck irradiation; prior thyroid surgery; symptoms or signs suggestive of dysfunction; thyroid antibodies, primarily TPO‐Ab; type 1 diabetes or other autoimmune diseases; infertility; prior miscarriage or preterm birth; iodine‐deficient population; medications and iodinated contrast media; morbid obesity (<a href="./references#CD011263-bbs2-0046" title="Stagnaro‐GreenA , AbalovichM , AlexanderE , AziziF , MestmanJ , NegroR , et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid2011;21(10):1081–125. ">Stagnaro‐Green 2011</a>)). Within individual guidelines, recommendations have also been found to differ. The Endocrine Society Task Force highlight in their guideline the lack of agreement reached regarding screening, noting that some members supported a universal screening approach to test for serum TSH abnormalities in pregnancy (prior to the ninth week of pregnancy, or at the initial visit), while other members supported an aggressive case finding approach (<a href="./references#CD011263-bbs2-0013" title="DeGrootL , AbalovichM , AlexanderE , AminoN , BarbourL , CobinR , et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism2012;97(8):2543‐65. ">De Groot 2012</a>). </p> </section> <section id="CD011263-sec-0037"> <h3 class="title" id="CD011263-sec-0037">How the intervention might work</h3> <p>It has been suggested that screening based on a 'case finding' approach may fail to detect a large proportion of hypothyroid and hyperthyroid women, whose thyroid dysfunction would thus remain uncontrolled throughout their pregnancies (<a href="./references#CD011263-bbs2-0011" title="ChangD , PearceE . Screening for maternal thyroid dysfunction in pregnancy: a review of the clinical evidence and current guidelines. Journal of Thyroid Research2013;2013:851326. ">Chang 2013</a>); subclinical hypothyroidism and thyroid autoimmunity in particular, present with few or no obvious clinical symptoms (<a href="./references#CD011263-bbs2-0053" title="VissenbergR , van denBoogaardE , vanWelyM , van derPostJA , FliersE , BisschopPH , et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Human Reproduction Update2012;18(4):360‐73. ">Vissenberg 2012</a>). Thus, debate currently ensues surrounding the ideal strategy to identify thyroid dysfunction in pregnancy, particularly regarding the role of universal screening for all pregnant women, versus case finding. </p> <p>A number of studies have assessed the effectiveness of current guidelines that emphasise targeted case finding of women with thyroid dysfunction before or during pregnancy, and their results have provided some support for the consideration of a universal screening approach. In a sample of 400 women, Horacek et al reported that over half (55%) of pregnant women with abnormalities detected in thyroid‐related tests would have been overlooked if only high‐risk case finding criteria were applied (<a href="./references#CD011263-bbs2-0028" title="HoracekJ , SpitalnikovaS , DlabalovaB , MalirovaE , VizdaJ , SvillasI , et al. Universal screening detects two‐times more thyroid disorders in early pregnancy than targeted high‐risk case finding. European Journal of Endocrinology2010;163(4):645‐50. ">Horacek 2010</a>). Similarly, Vaidya et al revealed, in a sample of 1560 pregnant women, that specific targeting of only high‐risk women would miss an estimated one‐third of women with OH or SH (<a href="./references#CD011263-bbs2-0051" title="VaidyaB , AnthonyS , BilousM , ShieldsB , DruryJ , HutchisonS , et al. Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high‐risk case finding?. Journal of Clinical Endocrinology and Metabolism2007;92(1):203‐7. ">Vaidya 2007</a>). In an assessment of thyroid testing and dysfunction rates at a medical centre in Boston, United States, Chang et al concluded that targeted testing for thyroid dysfunction would have missed approximately 80% of women with hypothyroidism during pregnancy (<a href="./references#CD011263-bbs2-0010" title="ChangDL , LeungAM , BravermanLE , PearceEN . Thyroid testing during pregnancy at an academic Boston Area Medical Center. Journal of Clinical Endocrinology and Metabolism2011;96(9):1452‐6. ">Chang 2011</a>). </p> <p>While universal screening may have the potential to identify a larger proportion of pregnant women with thyroid dysfunction and therefore facilitate earlier intervention and management, the implications of such an approach must be considered, including significant costs associated with treatment, follow‐up and monitoring; and the possibility of misinterpretation of thyroid function tests, leading to over diagnosis/misdiagnosis, and the initiation of inappropriate management strategies (<a href="./references#CD011263-bbs2-0011" title="ChangD , PearceE . Screening for maternal thyroid dysfunction in pregnancy: a review of the clinical evidence and current guidelines. Journal of Thyroid Research2013;2013:851326. ">Chang 2013</a>). In regards to the cost‐effectiveness of a universal screening approach (compared with case finding), two evaluation studies considering SH (<a href="./references#CD011263-bbs2-0050" title="ThungSF , FunaiEF , GrobmanWA . The cost‐effectiveness of universal screening in pregnancy for subclinical hypothyroidism. American Journal of Obstetrics and Gynecology2009;200(3):267.e1‐7. ">Thung 2009</a>), and autoimmune thyroid disease (<a href="./references#CD011263-bbs2-0014" title="DosiouC , BarnesJ , SchwartzA , NegroR , CrapoL , Stagnaro‐GreenA . Cost‐effectiveness of universal and risk‐based screening for autoimmune thyroid disease in pregnant women. Journal of Clinical Endocrinology and Metabolism2012;97(5):1536‐46. ">Dosiou 2012</a>) in pregnancy both indicated that universal screening would in fact be a cost‐effective tool, under a range of circumstances. </p> </section> <section id="CD011263-sec-0038"> <h3 class="title" id="CD011263-sec-0038">Why it is important to do this review</h3> <p>There is clearly documented evidence of morbidity and mortality associated with thyroid dysfunction (both hyper‐ and hypothyroidism) in pregnancy; thyroid dysfunction is associated with increased risks of a multitude of adverse outcomes for both the mother and her infant in the short‐ and long‐term. While two Cochrane reviews have assessed interventions for the treatment of thyroid dysfunction pre‐pregnancy and during pregnancy (<a href="./references#CD011263-bbs2-0015" title="EarlR , CrowtherCA , MiddletonP . Interventions for hyperthyroidism pre‐pregnancy and during pregnancy. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD008633.pub2] ">Earl 2013</a>; <a href="./references#CD011263-bbs2-0040" title="ReidSM , MiddletonP , CossichMC , CrowtherCA , BainE . Interventions for clinical and subclinical hypothyroidism pre‐pregnancy and during pregnancy. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD007752.pub3] ">Reid 2013</a>), no systematic review has assessed the effects of different methods of screening for thyroid dysfunction during pre‐pregnancy and during pregnancy (including universal screening versus case finding), for the identification and subsequent management of thyroid disease. </p> <p>Observational data from a number of studies have suggested that a large proportion of women with thyroid dysfunction in pregnancy are overlooked when targeted case finding methods are utilised (<a href="./references#CD011263-bbs2-0010" title="ChangDL , LeungAM , BravermanLE , PearceEN . Thyroid testing during pregnancy at an academic Boston Area Medical Center. Journal of Clinical Endocrinology and Metabolism2011;96(9):1452‐6. ">Chang 2011</a>; <a href="./references#CD011263-bbs2-0028" title="HoracekJ , SpitalnikovaS , DlabalovaB , MalirovaE , VizdaJ , SvillasI , et al. Universal screening detects two‐times more thyroid disorders in early pregnancy than targeted high‐risk case finding. European Journal of Endocrinology2010;163(4):645‐50. ">Horacek 2010</a>; <a href="./references#CD011263-bbs2-0051" title="VaidyaB , AnthonyS , BilousM , ShieldsB , DruryJ , HutchisonS , et al. Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high‐risk case finding?. Journal of Clinical Endocrinology and Metabolism2007;92(1):203‐7. ">Vaidya 2007</a>). It is therefore important to conduct this review to assess the effectiveness of different methods of screening for thyroid dysfunction in pregnancy on detection, subsequent management, health outcomes and costs of care. It is plausible that universal screening (as compared with case finding) may facilitate improved diagnosis and early management of thyroid disease in pregnancy, and thus may assist in reducing associated maternal and infant complications. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011263-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011263-sec-0039"></div> <p>To assess the effects of different screening methods (and subsequent management) for thyroid dysfunction pre‐pregnancy and during pregnancy on maternal and infant outcomes. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011263-sec-0040" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011263-sec-0040"></div> <section id="CD011263-sec-0041"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011263-sec-0042"> <h4 class="title">Types of studies</h4> <p>We planned to include randomised controlled trials, quasi‐randomised controlled trials and cluster‐randomised trials. We planned to exclude cross‐over trials. We planned to include studies published in abstract form only, along with those published in full‐text form. </p> </section> <section id="CD011263-sec-0043"> <h4 class="title">Types of participants</h4> <p>Women, either pre‐pregnancy or during pregnancy (including both singleton and multiple pregnancies). We excluded women with a pre‐existing diagnosis of thyroid dysfunction. </p> </section> <section id="CD011263-sec-0044"> <h4 class="title">Types of interventions</h4> <p>We included trials where any screening method (e.g. tool, program, guideline or protocol) for detecting thyroid dysfunction (including hypothyroidism, hyperthyroidism, and/or thyroid autoimmunity) pre‐pregnancy or during pregnancy was compared with no screening. </p> <p>We also included trials where two or more methods of screening were compared (e.g. case finding versus universal screening). </p> </section> <section id="CD011263-sec-0045"> <h4 class="title">Types of outcome measures</h4> <section id="CD011263-sec-0046"> <h5 class="title">Primary outcomes</h5> <section id="CD011263-sec-0047"> <h6 class="title">Maternal</h6> <p> <ol id="CD011263-list-0001"> <li> <p>Diagnosis of thyroid dysfunction (as determined by individual trialists)</p> <ol id="CD011263-list-0002"> <li> <p>Hypothyroidism (overt; subclinical; isolated hypothyroxinaemia)</p> </li> <li> <p>Hyperthyroidism (Graves' diseases; gestational thyrotoxicosis)</p> </li> <li> <p>Thyroid autoimmunity</p> </li> </ol> </li> <li> <p>Pre‐eclampsia</p> </li> </ol> </p> </section> <section id="CD011263-sec-0048"> <h6 class="title">Infant</h6> <p> <ol id="CD011263-list-0003"> <li> <p>Preterm birth (less than 37 weeks' gestation)</p> </li> </ol> </p> </section> <section id="CD011263-sec-0049"> <h6 class="title">Infant as child</h6> <p> <ol id="CD011263-list-0004"> <li> <p>Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment, at latest time reported) </p> </li> </ol> </p> </section> </section> <section id="CD011263-sec-0050"> <h5 class="title">Secondary outcomes</h5> <section id="CD011263-sec-0051"> <h6 class="title">Maternal</h6> <p> <ol id="CD011263-list-0005"> <li> <p>Overall clinical improvement in symptoms of:</p> <ol id="CD011263-list-0006"> <li> <p>hypothyroidism</p> </li> <li> <p>hyperthyroidism</p> </li> <li> <p>thyroid autoimmunity</p> </li> </ol> </li> <li> <p>Pharmacological treatment required to manage thyroid dysfunction</p> <ol id="CD011263-list-0007"> <li> <p>e.g. levothyroxine treatment for hypothyroidism</p> </li> <li> <p>e.g. propylthiouracil or carbimazole treatment for hyperthyroidism</p> </li> </ol> </li> <li> <p>Miscarriage</p> </li> <li> <p>Pregnancy‐induced hypertension</p> </li> <li> <p>Gestational diabetes</p> </li> <li> <p>Glucose tolerance measures (e.g. glycated haemoglobin (HbA1c) concentration)</p> </li> <li> <p>Anaemia</p> </li> <li> <p>Congestive heart failure</p> </li> <li> <p>Thyroid storm</p> </li> <li> <p>Mode of birth (normal vaginal birth, operative vaginal birth, caesarean section)</p> </li> <li> <p>Induction of labour</p> </li> <li> <p>Preterm labour</p> </li> <li> <p>Placental abruption</p> </li> <li> <p>Postpartum haemorrhage</p> </li> <li> <p>Weight change (e.g. excessive weight gain/loss in pregnancy)</p> </li> <li> <p>Quality of life</p> </li> <li> <p>Adverse effects associated with the intervention</p> </li> <li> <p>Postpartum thyroid dysfunction</p> </li> <li> <p>Postnatal depression</p> </li> <li> <p>Infertility</p> </li> <li> <p>Maternal death</p> </li> </ol> </p> </section> <section id="CD011263-sec-0052"> <h6 class="title">Fetal/neonatal/infant</h6> <p> <ol id="CD011263-list-0008"> <li> <p>Death (defined as all fetal and neonatal deaths)</p> </li> <li> <p>Fetal death</p> </li> <li> <p>Neonatal death</p> </li> <li> <p>Respiratory distress syndrome</p> </li> <li> <p>Low birthweight</p> </li> <li> <p>Small‐for‐gestational age (defined as birthweight less that 10th centile)</p> </li> <li> <p>Neonatal intensive care unit (or special care unit) admission</p> </li> <li> <p>Abnormal thyroid function (e.g. neonatal hyperthyroidism; neonatal goitre; cretinism – defined as congenital hypothyroidism resulting in impaired physical and mental development) </p> </li> <li> <p>Other congenital malformations</p> </li> </ol> </p> </section> <section id="CD011263-sec-0053"> <h6 class="title">Infant as child</h6> <p> <ol id="CD011263-list-0009"> <li> <p>Cerebral palsy</p> </li> <li> <p>Blindness: corrected visual acuity worse than 6/60 in the better eye</p> </li> <li> <p>Deafness: hearing loss requiring amplification or worse</p> </li> <li> <p>Developmental delay/intellectual impairment</p> </li> </ol> </p> </section> <section id="CD011263-sec-0054"> <h6 class="title">Health services</h6> <p> <ol id="CD011263-list-0010"> <li> <p>Maternal length of hospital stay</p> </li> <li> <p>Neonatal length of hospital stay</p> </li> <li> <p>Cost of screening</p> </li> <li> <p>Costs of maternal and neonatal/infant care</p> </li> </ol> </p> <p>*Unless specified, for all outcomes above, we planned to include outcome data reported according to outcome definitions determined/specified by the trialists </p> </section> </section> </section> </section> <section id="CD011263-sec-0055"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD011263-sec-0056"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register by contacting the Trials Search Co‐ordinator (14 July 2015). </p> <p>The Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from: </p> <p> <ol id="CD011263-list-0011"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Details of the search strategies for CENTRAL, MEDLINE, Embase and CINAHL, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the ‘Specialized Register’ section within the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth Group</a>. </p> <p>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co‐ordinator searches the register for each review using the topic list rather than keywords. </p> </section> <section id="CD011263-sec-0057"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of all retrieved studies.</p> <p>We did not apply any date or language restrictions.</p> </section> </section> <section id="CD011263-sec-0058"> <h3 class="title" id="CD011263-sec-0058">Data collection and analysis</h3> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD011263-sec-0059"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies identified as a result of the search strategy. We resolved any disagreement through discussion or, if required, we consulted the third review author. </p> </section> <section id="CD011263-sec-0060"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted the third review author. Data were entered into Review Manager software (<a href="./references#CD011263-bbs2-0041" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and checked for accuracy. </p> <p>If information regarding any of the above was unclear, we planned to contact authors of the original reports to provide further details. </p> </section> <section id="CD011263-sec-0061"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="http://archie.cochrane.org/sections/documents/view?version=z1212181516253162684622876719716%26format=REVMAN_GRAPHS#REF-Higgins-2011" target="_blank">Higgins 2011</a>). Any disagreement was resolved by discussion or by involving a third assessor. </p> <section id="CD011263-sec-0062"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD011263-list-0012"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD011263-sec-0063"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD011263-list-0013"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD011263-sec-0064"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD011263-list-0014"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD011263-sec-0065"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD011263-list-0015"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD011263-sec-0066"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re‐include missing data in the analyses which we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD011263-list-0016"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD011263-sec-0067"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD011263-list-0017"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD011263-sec-0068"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we had about other possible sources of bias. </p> </section> <section id="CD011263-sec-0069"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="http://archie.cochrane.org/sections/documents/view?version=z1212181516253162684622876719716%26format=REVMAN_GRAPHS#REF-Higgins-2011" target="_blank">Higgins 2011</a>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings. In future updates, we will explore the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD011263-sec-0083">Sensitivity analysis</a>. </p> </section> <section id="CD011263-sec-0070"> <h5 class="title">Assessing the quality of the body of evidence using the GRADE approach</h5> <p>We assessed the quality of the evidence using the GRADE approach (<a href="./references#CD011263-bbs2-0043" title="SchunemannHJ . GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice [GRADE: Von der Evidenz zur Empfehlung. Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen2009;103(6):391‐400. ">Schunemann 2009</a>) in order to assess the quality of the body of evidence relating to the following outcomes for the review's two comparisons. </p> <p> <ol id="CD011263-list-0018"> <li> <p>Diagnosis of thyroid dysfunction (as determined by individual trialists)</p> <ol id="CD011263-list-0019"> <li> <p>Hypothyroidism (overt; subclinical; isolated hypothyroxinaemia)</p> </li> <li> <p>Hyperthyroidism (Graves' diseases; gestational thyrotoxicosis)</p> </li> </ol> </li> <li> <p>Pre‐eclampsia</p> </li> <li> <p>Preterm birth (less than 37 weeks' gestation)</p> </li> <li> <p>Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment, at latest time reported) </p> </li> <li> <p>Miscarriage</p> </li> <li> <p>Adverse effects associated with the intervention</p> </li> <li> <p>Death (defined as all fetal and neonatal deaths)</p> </li> </ol> </p> <p>We used GRADE profiler (<a href="./references#CD011263-bbs2-0023" title="McMaster University. GRADEpro. [Computer program on www.gradepro.org]. Version 2015. McMaster University, 2014. ">GRADE 2014</a>) to import data from Review Manager 5.3 (<a href="./references#CD011263-bbs2-0041" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) in order to create 'Summary of findings' tables. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> <section id="CD011263-sec-0071"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> <section id="CD011263-sec-0072"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference. We planned to use the standardised mean difference to combine trials that measured the same outcome, but used different methods. </p> </section> </section> <section id="CD011263-sec-0073"> <h4 class="title">Unit of analysis issues</h4> <section id="CD011263-sec-0074"> <h5 class="title">Cluster‐randomised trials</h5> <p>We planned to include cluster‐randomised trials in the analyses along with individually‐randomised trials. In future updates of this review, if we include cluster‐randomised trials and if clustering has not been taken into account in the trial's analysis, we plan to adjust the trial's sample sizes using the methods described in the <i>Handbook</i> (<a href="./references#CD011263-bbs2-0026" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We also plan to acknowledge heterogeneity in the randomisation unit and plan to perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD011263-sec-0075"> <h5 class="title">Cross‐over trials</h5> <p>Cross‐over trials were considered inappropriate for this review question.</p> </section> <section id="CD011263-sec-0076"> <h5 class="title">Multiple pregnancies</h5> <p>As infants from multiple pregnancies are not independent, we planned to use cluster trial methods in the analyses, if the data allowed, and if multiples made up a substantial proportion of the trial population, to account for non‐independence of variables (<a href="./references#CD011263-bbs2-0018" title="GatesS , BrocklehurstP . How should trials recruiting women with multiple pregnancies be analysed?. British Journal of Obstetrics and Gynaecology2004;111:213‐9. ">Gates 2004</a>). </p> </section> <section id="CD011263-sec-0077"> <h5 class="title">Multi‐armed studies</h5> <p>If we included studies using one or more treatment groups (multi‐arm studies) where appropriate, we planned to combine groups to create a single pair‐wise comparison. We planned to use methods described in the <i>Handbook</i> (<a href="./references#CD011263-bbs2-0026" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) to ensure that we did not double count participants. </p> </section> </section> <section id="CD011263-sec-0078"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, levels of attrition were noted. In future updates, if more eligible studies are included, the impact of including studies with high levels of missing data in the overall assessment of treatment effect will be explored by using sensitivity analysis. </p> <p>For all outcomes, analyses were carried out, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> <p>Had we included studies where women were recruited preconception, for outcomes relating to pregnancy, we planned to take a pragmatic approach and include in the denominators only those women known to have become pregnant. </p> </section> <section id="CD011263-sec-0079"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to assess statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We would have regarded heterogeneity as substantial if an I² was greater than 30% and either a Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. If we had identified substantial heterogeneity (above 30%), we planned to explore it by pre‐specified subgroup analysis. </p> </section> <section id="CD011263-sec-0080"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates, if there are 10 or more studies in the meta‐analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD011263-sec-0081"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager software (<a href="./references#CD011263-bbs2-0041" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We planned to use fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. </p> <p>If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we planned to use random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. We would have treated the random‐effects summary as the average range of possible treatment effects and discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we planned to not combine trials. If we had used random‐effects analyses, we planned to present the results as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> <p>We planned to consider trials screening for specific categories of thyroid dysfunction (i.e. hypothyroidism, hyperthyroidism) versus those trials screening for any thyroid dysfunction. </p> <p>We planned to consider the following comparisons in this review:</p> <p> <ol id="CD011263-list-0020"> <li> <p>Any screening method (tool, guidelines, protocol) versus no screening (in this review we compare universal screening versus no screening in pregnancy for hypothyroidism) </p> </li> <li> <p>One method of screening versus a different method of screening, such as case finding versus universal screening ‐ (in this review we compare universal screening versus case finding in pregnancy for any thyroid dysfunction) </p> </li> </ol> </p> </section> <section id="CD011263-sec-0082"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we had conducted meta‐analyses, and had identified substantial heterogeneity, we planned to investigate it using subgroup analyses and sensitivity analyses. We planned to consider whether an overall summary was meaningful, and if it was, we would have used random‐effects analysis to produce it. </p> <p>We planned to carry out the following subgroup analyses, for primary outcomes.</p> <p> <ol id="CD011263-list-0021"> <li> <p>gestational age at screening for dysfunction used in the trial (e.g. preconception versus first trimester versus second trimester versus third trimester); </p> </li> <li> <p>type of screening method/protocol used in the trial (e.g. case finding (based on symptoms/history only) versus 'aggressive' case finding (based on a range of risk factors)); </p> </li> <li> <p>baseline risk for thyroid dysfunction of women in the trial (e.g. high risk for thyroid dysfunction (i.e. symptomatic women; women with a family history; other risk factors) versus low risk for dysfunction). </p> </li> </ol> </p> <p>However, largely (except for considering baseline risk for thyroid dysfunction as reported in one trial) we were not able to conduct subgroup analyses due to paucity of data. </p> <p>We planned to assess subgroup differences by interaction tests available within RevMan (<a href="./references#CD011263-bbs2-0041" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We planned to report the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD011263-sec-0083"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to carry out sensitivity analyses to explore the effects of trial quality and trial design on the outcomes. However, planned sensitivity analyses were not conducted due to paucity of data. In future updates of this review, we will carry out planned sensitivity analysis for this review's primary outcomes, if required. We will explore the effects of trial quality assessed by allocation concealment and random sequence generation (considering selection bias), by omitting studies rated as 'high risk of bias' (including quasi‐randomised trials) or 'unclear risk of bias' for these components. We will investigate the effects of the randomisation unit (individual versus cluster) on the outcomes, and the impact of including studies with high levels of missing data. We will explore the effects of fixed‐effect or random‐effects analyses for outcomes with statistical heterogeneity, and the effects of any assumptions made such as the value of the ICC used for cluster‐randomised trials. We will restrict this to the primary outcomes. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011263-sec-0084" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011263-sec-0084"></div> <section id="CD011263-sec-0085"> <h3 class="title">Description of studies</h3> <section id="CD011263-sec-0086"> <h4 class="title">Results of the search</h4> <p>The search of the Cochrane Pregnancy and Childbirth Group's Trials Register retrieved four records (see: <a href="#CD011263-fig-0001">Figure 1</a>). One record related to an ongoing study (<a href="./references#CD011263-bbs2-0003" title="TengW . Screening and intervention for iodine deficiency, iron deficiency and subclinical thyroid insufficiency in women planning pregnancy and in early pregnant women. Chinese Clinical Trial Registry (http://www.chictr.org/en/) [accessed 30 April 2015]2013. ">Teng 2013</a>, see <a href="./references#CD011263-sec-0167" title="">Characteristics of ongoing studies</a>). The other three records related to two trials, both of which met the review's pre‐defined inclusion criteria. (<a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>; <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). One of the three records describes the protocol for ongoing follow‐up of children from the <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> trial, which is ongoing. </p> <div class="figure" id="CD011263-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011263-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011263-sec-0087"> <h4 class="title">Included studies</h4> <p>Two randomised controlled trials were included in this review (<a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>; <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). A total of 26,408 women and their babies were involved in the two trials. </p> <section id="CD011263-sec-0088"> <h5 class="title">Settings</h5> <p>Both trials recruited pregnant women from hospitals in Europe. <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> recruited women from 10 hospitals in the United Kingdom and one hospital in Italy. <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> recruited women from two hospitals in Italy. </p> </section> <section id="CD011263-sec-0089"> <h5 class="title">Participants</h5> <p>All study participants were pregnant women. <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> recruited women with a singleton pregnancy, prior to the first 11 weeks of gestation and excluded women with a history of thyroid disease. All women included in this trial were Caucasian, with a mean age of 28.9 and 28.7 years in the case finding and universal screening groups respectively. </p> <p><a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> recruited pregnant women at their first antenatal hospital appointment up to 15 weeks and six days' gestation. Women less than 18 years of age, with a twin pregnancy or known thyroid disease were excluded. Baseline maternal characteristics were similar between the screening and no screening group, with a mean maternal age at delivery of 30 and 31 years for each group respectively. Children of women who tested positive for hypothyroidism in both the screening and no screening groups were followed up at three years of age for psychological testing. The median age of children at the time of psychological testing in both groups was 3.2 years (interquartile range of 3.2 to 3.3). </p> </section> <section id="CD011263-sec-0090"> <h5 class="title">Interventions</h5> <p>One included trial (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>) was designed to assess treatment of thyroid dysfunction during pregnancy comparing 'universal screening' to 'case finding' methods. All women had a blood sample taken at their first antenatal visit and discussed any risk factors with an obstetrician. Women were considered 'high risk' if they had any one of the following risk factors: family history for autoimmune thyroid disease, presence of goitre, signs and symptoms suggestive for thyroid dysfunction, personal history for type 1 diabetes or other autoimmune disease, history of neck irradiation, previous miscarriages, or preterm deliveries (included in The Endocrine Society’s guidelines for screening high‐risk women) (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). In the universal screening group, all women had their sera tested immediately for TSH, free T4 (fT4), and thyroid peroxidase antibody (TPO‐Ab) status. Women in the 'case finding' group who were considered 'high risk' had their sera tested immediately for TSH, free T4 (fT4), and thyroid peroxidase antibody (TPO‐Ab) status. Women in the 'case finding' group who were considered 'low risk' had their sera frozen and assayed postpartum (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). </p> <p>For both groups (all women in universal screening group and 'high‐risk' women in case finding group) in the <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> study, women were classified as hypothyroid (TSH greater than 2.5 mIU/litre in TPO‐Ab+ women), hyperthyroid (undetectable TSH concentration and elevated fT4), or euthyroid; with hypothyroid and hyperthyroid women referred to an endocrinologist by the 12th gestational week. In women identified as hypothyroid at initial screening, levothyroxine was initiated and titrated during the first trimester to maintain TSH concentration less than 2.5 mIU/litre (and less than 3 mIU/litre in the second and third trimesters). In women identified as hyperthyroid, treatment was based on clinical judgement – methimazole or propylthiouracil was administered, where necessary, to keep fT4 concentrations around the upper limit or normal, and to avoid undetectable TSH values. All women with thyroid dysfunction had thyroid function tests performed at least once during the second and third trimesters. </p> <p>The second included trial (<a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>), compared antenatal screening and subsequent treatment for hypothyroidism versus no screening. All women had a blood sample obtained on trial entry. Women in the screening group had their sample assayed for TSH and fT4 immediately, whereas women in the control group (no screening) had their sample frozen, to be assayed for TSH and fT4 after birth. Women in the screening group were considered to have screened ‘positive’ if their TSH concentration was above the 97.5th percentile, their fT4 concentration was below the 2.5th percentile, or both. Women who screened positive for hypothyroidism in this group were treated with levothyroxine, 150 μg per day. Concentrations of TSH and fT4 were checked six weeks after the start of levothyroxine therapy and at 30 weeks’ gestation with adjustment of the dose as necessary (target TSH concentration was 0.1 to 1.0 mIU/litre). All women in both the screening and control groups received routine care. Women who received positive test results in both groups were advised to visit their family physician after birth to determine if levothyroxine should be continued or initiated. </p> </section> <section id="CD011263-sec-0091"> <h5 class="title">Outcomes</h5> <p>The primary outcome for one trial (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>) was obstetric and neonatal complications (composite outcome). Adverse obstetric and neonatal complications were obtained from a review of medical records and included: miscarriage, hypertension, pre‐eclampsia, gestational diabetes, placental abruption, thyroid storm, caesarean birth, congestive heart failure, preterm labour, respiratory distress, neonatal intensive care unit admission, low birthweight, high birthweight, preterm (34 to 37 weeks) or very preterm (less than four weeks) birth, Apgar score of three or less at five minutes, perinatal/neonatal death, and other (intraventricular haemorrhage, umbilical artery blood pH less than 7.0, necrotising enterocolitis or major malformations). </p> <p>The primary outcome for the second trial (<a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>) was intelligence quotient (IQ) at three years of age, and IQ of less than 85 in children of women who tested positive for hypothyroidism. IQ was assessed using the Weschsler Preschool and Primary Scale of Intelligence (<a href="./references#CD011263-bbs2-0054" title="Wechsler , D . Wechsler Pre‐school and Primary Scale of Intelligence. Third Edition. Psychological Corporation, 2003. ">Wechsler 2003</a>) by psychologists who visited the children at home. Child behaviour was also assessed at three years of age with the Child Behaviour Checklist (<a href="./references#CD011263-bbs2-0004" title="Achenbach , T . Child Behaviour Checklist. Achenbach System of Empirically Based Assessment, University of Vermont, 2000. ">Achenbach 2000</a>) and Brief‐P (<a href="./references#CD011263-bbs2-0021" title="GioiaGA , Andrews EspyK , IsquithPK . Behavior Rating Rating Inventory of Executive Function ‐ Preschool Version (Brief‐P). Psychological Assessment Resources, 2003. ">Gioia 2003</a>) resources. Maternal psychological status was assessed with the Beck Depression Inventory II (<a href="./references#CD011263-bbs2-0006" title="BeckAT , SteerRA , BrownGK . Beck Depression Inventory II. Psychological Corporation, 1996. ">Beck 1996</a>). </p> </section> </section> <section id="CD011263-sec-0092"> <h4 class="title">Excluded studies</h4> <p>We did not exclude any trials from this review.</p> </section> </section> <section id="CD011263-sec-0093"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall, the two trials were judged to be of low risk of bias (see <a href="#CD011263-fig-0002">Figure 2</a>; <a href="#CD011263-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD011263-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011263-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011263-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011263-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011263-sec-0094"> <h4 class="title">Allocation</h4> <p>Both trials (<a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>; <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>) were judged to have used adequate methods to generate a random sequence with each trial using computer‐generated random numbers. Both trials also used adequate methods for allocation concealment. In <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>, allocation was concealed by using a central laboratory for randomisation, while sealed, opaque envelopes were used in the <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> trial. </p> </section> <section id="CD011263-sec-0095"> <h4 class="title">Blinding</h4> <p>In <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>, the obstetricians and endocrinologists were blinded to group assignment (and these staff members collected outcome data blinded), and therefore the trial was judged to be at a low risk of both performance and detection bias. There was no mention of blinding in the <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> trial, however, in view of the nature of the intervention blinding of study participants and personnel was considered unlikely and therefore judged to be at an unclear risk of detection bias. <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> did however blind psychologists who performed IQ assessments at three years of age for the children; thus the trial was judged to be at low risk of detection bias. </p> </section> <section id="CD011263-sec-0096"> <h4 class="title">Incomplete outcome data</h4> <p>The <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> trial was judged to be at a low risk of attrition bias given the low number (1%) of women lost to follow‐up and with similar numbers and reasons for losses between groups.<br/> Although the <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> trial employed intention‐to‐treat principles in their primary analyses and the numbers of women lost to follow‐up were similar across both screening and control groups (90 versus 106), there was a higher number of women in the control group who declined to have their child assessed (19 versus 41); psychological testing was only completed in 78.2% (390/499) of the positive screening group and 73.3% (404/551) of positive control group at three years. While the authors reported that <i>“A sensitivity analysis indicated that the higher rate of declined assessment in the control group than in the screening group is extremely unlikely to explain our results”</i> the risk of attrition bias was judged unclear. </p> </section> <section id="CD011263-sec-0097"> <h4 class="title">Selective reporting</h4> <p>Although the authors in <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> state that <i>“adverse outcomes were prospectively defined”,</i> there was no access to a trial protocol to confirm if all pre‐specified outcomes were reported therefore the trial was judged to be at an unclear risk of reporting bias. In <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>, the trial protocol was easily accessible as Supplementary Material and indicated that in August 2004 a decision was made by all the investigators to perform IQ and other psychological assessment of children once at three years of age instead of twice at age two and age five. Mothers were informed by letter, of the protocol change in October 2004. The trial protocol also discussed maternal urine collection for iodine measurement, which was not reported in the manuscript. Apart from birthweight, preterm birth and gestational age at birth, no other important or expected maternal or perinatal outcomes were reported. For these reasons the trial was also judged to be at an unclear risk of reporting bias </p> </section> <section id="CD011263-sec-0098"> <h4 class="title">Other potential sources of bias</h4> <p>Both included trials (<a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>; <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>) were judged to be at low risk of other potential bias, with no obvious sources of bias identified. </p> </section> </section> <section id="CD011263-sec-0099"> <h3 class="title" id="CD011263-sec-0099">Effects of interventions</h3> <p>See: <a href="./full#CD011263-tbl-0001"><b>Summary of findings for the main comparison</b> Universal screening versus case finding in pregnancy for any thyroid dysfunction</a>; <a href="./full#CD011263-tbl-0002"><b>Summary of findings 2</b> Universal screening versus no screening in pregnancy for hypothyroidism</a> </p> <section id="CD011263-sec-0100"> <h4 class="title">Universal screening versus case finding in pregnancy for any thyroid dysfunction</h4> <p>See <a href="./full#CD011263-tbl-0001">summary of findings Table for the main comparison</a> for the first comparison 'Universal screening versus case finding in pregnancy for any thyroid dysfunction'. </p> <section id="CD011263-sec-0101"> <h5 class="title">Primary outcomes</h5> <section id="CD011263-sec-0102"> <h6 class="title">Maternal</h6> <section id="CD011263-sec-0103"> <p><b>Maternal diagnosis of thyroid dysfunction</b></p> <p><a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> compared universal screening with case finding and reported data on maternal diagnosis of thyroid dysfunction. All women in the universal screening group had their sera (taken at their first obstetric visit) tested immediately for TSH, fT4 and TPO‐Ab, while for women in the case finding group, only those classified as 'high risk' had their sera tested immediately, and 'low‐risk' women had sera frozen and assayed postpartum (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). For both groups, diagnosis of maternal thyroid dysfunction was classified as follows: hypothyroid (TSH &gt; 2.5mlU/litre in TPO‐Ab+ women), hyperthyroid (undetectable TSH concentration and elevated fT4) or euthyroid (with or without antibodies). </p> <p>In pregnancy, compared with the case finding group, more women in the universal screening group were diagnosed with hypothyroidism (risk ratio (RR) 3.15, 95% confidence interval (CI) 1.91 to 5.20; 4562 women; GRADE: <i>high quality evidence</i>) (<a href="./references#CD011263-fig-0004" title="">Analysis 1.1</a>); overall 2.8% (63/2280) of women were diagnosed with hypothyroidism in the universal screening group, compared with 0.9% (20/2282) of women in the case finding group. </p> <p>We conducted a subgroup analysis for this outcome, based on baseline risk for thyroid dysfunction ('low‐risk' versus 'high‐risk' classification). A clear subgroup difference was revealed for this outcome based on baseline risk (Chi²: 10.05, P = 0.002, I² = 90.1%). While there was no clear difference for hypothyroid diagnosis in pregnancy between universal screening and case finding methods for women classified as 'high risk' (RR 0.89, 95% CI 0.48 to 1.65; 936 women) (<a href="./references#CD011263-fig-0006" title="">Analysis 1.3</a>); for women classified as 'low risk', significantly more women in the universal screening group had a diagnosis of hypothyroidism in pregnancy (N = 44; versus no women in the case finding group, as these women had their sera frozen and it was not assayed until postpartum) (RR 90.48, 95% CI 5.58 to 1468.14; 3626 women) (<a href="./references#CD011263-fig-0006" title="">Analysis 1.3</a>). Of those women in the case finding 'low‐risk' group, whose serum samples were subsequently assayed postpartum, 34 were hypothyroid (who were thus not diagnosed or treated in pregnancy) (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). </p> <p>In pregnancy, compared with the universal screening group, there was a trend towards more women in the universal screening group being diagnosed with hyperthyroidism (RR 4.50, 95% CI 0.97 to 20.82; 4562 women; P = 0.05; GRADE: <i>moderate quality evidence</i>) (<a href="./references#CD011263-fig-0005" title="">Analysis 1.2</a>); overall 0.4% (9/2280) of women were diagnosed with hyperthyroidism in the universal screening group, compared with 0.1% (2/2282) of women in the case finding group. </p> <p>We conducted a subgroup analysis for this outcome, based on baseline risk for thyroid dysfunction ('low‐risk' versus 'high‐risk' classification). While there was no clear subgroup difference for this outcome based on baseline risk for thyroid dysfunction (Chi² = 2.48, P = 0.12, I² = 59.7%) and two 'high‐risk' women in both groups were diagnosed as hyperthyroid in pregnancy (RR 0.94, 95% CI 0.13 to 6.66; 936 women) (<a href="./references#CD011263-fig-0007" title="">Analysis 1.4</a>), there was a trend (P = 0.06) towards more 'low‐risk' women being diagnosed as hyperthyroid in pregnancy in the universal screening group, with seven diagnoses in the universal screening group compared with none in the case finding group (RR 15.25, 95% CI 0.87 to 266.82; 3626 women) (<a href="./references#CD011263-fig-0007" title="">Analysis 1.4</a>). When serum samples of 'low‐risk' case finding women were assayed postpartum, five women were subsequently classified as hyperthyroid. </p> <p>Therefore in <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>, of the 'low‐risk' case finding group, there was a total of 39 hyper/hypothyroid women who were not diagnosed (and thus not treated) in pregnancy (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). </p> </section> <section id="CD011263-sec-0104"> <p><b>Pre‐eclampsia</b></p> <p><a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> reported on pre‐eclampsia, and did not show a clear difference between the universal screening and case finding groups (RR 0.87, 95% CI 0.64 to 1.18; 4516 women; GRADE: <i>moderate quality evidence</i>) (<a href="./references#CD011263-fig-0008" title="">Analysis 1.5</a>). No clear subgroup difference was observed for this outcome when considering baseline risk for thyroid dysfunction ('low risk' versus 'high risk') (Chi² = 3.66, P = 0.45, I² = 0%) (<a href="./references#CD011263-fig-0009" title="">Analysis 1.6</a>). </p> </section> </section> <section id="CD011263-sec-0105"> <h6 class="title">Infant</h6> <section id="CD011263-sec-0106"> <p><b>Preterm birth</b></p> <p>There was no clear difference between the universal screening and case finding groups in the risk of preterm birth in <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> (RR 0.99, 95% CI 0.80 to 1.24; 4516 women; GRADE: <i>high quality evidence</i>) (<a href="./references#CD011263-fig-0010" title="">Analysis 1.7</a>). No clear subgroup difference was shown based on baseline risk for thyroid dysfunction for this outcome (Chi² = 3.04, P = 0.55, I² = 0%) (<a href="./references#CD011263-fig-0011" title="">Analysis 1.8</a>). </p> </section> </section> <section id="CD011263-sec-0107"> <h6 class="title">Infant as a child</h6> <section id="CD011263-sec-0108"> <p><b>Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment at latest time reported)</b></p> <p><a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> did not report on neurosensory disability for the child. </p> </section> </section> </section> <section id="CD011263-sec-0109"> <h5 class="title">Secondary outcomes</h5> <section id="CD011263-sec-0110"> <h6 class="title">Maternal</h6> <section id="CD011263-sec-0111"> <p><b>Pharmacological treatment required to manage thyroid dysfunction</b></p> <p>As expected, more women in the universal screening group received pharmacological treatment to manage their thyroid dysfunction (RR 3.15, 95% CI 1.91 to 5.20; 4562 women) (<a href="./references#CD011263-fig-0012" title="">Analysis 1.9</a>). All women (N = 63) in the universal screening group with a diagnosis of hypothyroidism received thyroxine, compared with only those 'high‐risk' women with a diagnosis of hypothyroidism in the case finding group (N = 20) (for the N = 34 'low‐risk' women classified as hypothyroid, their diagnosis was not known until their sera was assayed postpartum, and thus, they did not receive pharmacological treatment during pregnancy). </p> <p>In regards to pharmacological treatment for women diagnosed with hyperthyroidism, <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> reported that of the nine women in the universal screening group and seven in the case finding group with a diagnosis of hyperthyroidism, 11/16 were investigated (i.e. all nine women in the universal screening group, and only the two 'high‐risk' women in the case finding group, whose diagnosis was made during pregnancy (for the other five 'low‐risk' women in the case finding group, their diagnosis was not known until postpartum)). <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> reported that four of the 11 women were subsequently treated with antithyroid drugs in pregnancy; however it was not clear from which groups these women were from. </p> </section> <section id="CD011263-sec-0112"> <p><b>Miscarriage</b></p> <p>No clear difference between universal screening and case finding groups was observed in the risk of miscarriage (RR 0.90, 95% CI 0.68 to 1.19; 4516 women; GRADE: <i>moderate quality evidence</i>) (<a href="./references#CD011263-fig-0013" title="">Analysis 1.10</a>). </p> </section> <section id="CD011263-sec-0113"> <p><b>Pregnancy‐induced hypertension</b></p> <p><a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> reported on gestational hypertension, with no clear difference observed between the universal screening and case finding groups (RR 1.02 95% CI 0.80 to 1.29; 4516 women) (<a href="./references#CD011263-fig-0014" title="">Analysis 1.11</a>). </p> </section> <section id="CD011263-sec-0114"> <p><b>Gestational diabetes</b></p> <p><a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> reported no clear difference between the universal screening and case finding groups for the diagnosis of gestational diabetes (RR 0.93, 95% CI 0.70 to 1.25; 4516 women) (<a href="./references#CD011263-fig-0015" title="">Analysis 1.12</a>). </p> </section> <section id="CD011263-sec-0115"> <p><b>Congestive heart failure</b></p> <p>There were no cases of maternal congestive heart failure in the universal screening and case finding groups (<a href="./references#CD011263-fig-0016" title="">Analysis 1.13</a>) (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). </p> </section> <section id="CD011263-sec-0116"> <p><b>Thyroid storm</b></p> <p>There were no cases of maternal thyroid storm in the universal screening and case finding groups (<a href="./references#CD011263-fig-0017" title="">Analysis 1.14</a>) (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). </p> </section> <section id="CD011263-sec-0117"> <p><b>Mode of birth</b></p> <p><a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> reported on caesarean birth and showed no clear difference in caesarean birth risk between the universal screening and case finding groups (RR 1.07, 95% CI 0.95 to 1.20; 4516 women) (<a href="./references#CD011263-fig-0018" title="">Analysis 1.15</a>). </p> </section> <section id="CD011263-sec-0118"> <p><b>Preterm labour</b></p> <p>There was no clear difference observed between the universal screening and case finding groups in the risk of preterm labour (RR 1.18, 95% CI 0.93 to 1.49; 4516 women) (<a href="./references#CD011263-fig-0019" title="">Analysis 1.16</a>) (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). </p> </section> <section id="CD011263-sec-0119"> <p><b>Placental abruption</b></p> <p>There was no clear difference between the universal screening and case finding groups in the risk of placental abruption (RR 0.78, 95% CI 0.29 to 2.08; 4516 women) (<a href="./references#CD011263-fig-0020" title="">Analysis 1.17</a>) (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). </p> <p><a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> did not report outcome data on the following secondary outcomes for the mother: overall clinical improvement in symptoms; glucose tolerance measures; anaemia; induction of labour; postpartum haemorrhage; weight change; quality of life; adverse effects associated with the intervention; postpartum thyroid dysfunction; postnatal depression; infertility or maternal death. </p> </section> </section> <section id="CD011263-sec-0120"> <h6 class="title">Fetal/neonatal/infant</h6> <section id="CD011263-sec-0121"> <p><b>Death (defined as all fetal and neonatal death)</b></p> <p><a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> reported combined fetal and neonatal deaths with no clear difference observed between the universal screening and case finding groups (RR 0.92, 95% CI 0.42 to 2.02; 4516 infants; GRADE: <i>moderate quality evidence</i>) (<a href="./references#CD011263-fig-0021" title="">Analysis 1.18</a>). </p> </section> <section id="CD011263-sec-0122"> <p><b>Respiratory distress syndrome</b></p> <p>No clear difference in the risk of respiratory distress syndrome was observed between infants born to mothers from the universal screening group and those born to mothers from the case finding group (RR 0.79, 95% CI 0.48 to 1.31; 4516 infants) (<a href="./references#CD011263-fig-0022" title="">Analysis 1.19</a>) (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). </p> </section> <section id="CD011263-sec-0123"> <p><b>Low birthweight</b></p> <p><a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> defined low infant birthweight as &lt; 2500 g. No clear difference was observed in the risk of low birthweight between infants born to mothers from the universal screening and case finding groups (RR 0.97, 95% CI 0.74 to 1.27; 4516 infants) (<a href="./references#CD011263-fig-0023" title="">Analysis 1.20</a>). </p> </section> <section id="CD011263-sec-0124"> <p><b>Neonatal intensive care unit (or special care unit) admission</b></p> <p>There was no difference in risk of admission to the neonatal intensive care unit for infants born to mothers from the universal screening and case finding groups (RR 1.04, 95% CI 0.81 to 1.34; 4516 infants) (<a href="./references#CD011263-fig-0024" title="">Analysis 1.21</a>) (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). </p> </section> <section id="CD011263-sec-0125"> <p><b>Other congenital malformations</b></p> <p><a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> reported on congenital malformations within a combined outcome titled 'Other Complications'. This included intraventricular haemorrhage, umbilical artery blood pH of &lt; 7.0, necrotising enterocolitis, or major malformations. There was no clear difference between infants born to mothers from the universal screening and case finding groups for this outcome (RR 1.00, 95% CI 0.51 to 1.95; 4516 infants (<a href="./references#CD011263-fig-0025" title="">Analysis 1.22</a>). </p> </section> </section> <section id="CD011263-sec-0126"> <h6 class="title">Secondary outcomes not reported under this comparison</h6> <p><a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> did not report outcome data on the following secondary outcomes for the fetus/neonate/infant: small for gestational age, abnormal thyroid function, and additionally did not report outcome data on the following secondary outcomes for the infant as a child: cerebral palsy, blindness, deafness. </p> <p><a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> did not report on any outcomes relating to the use of health services. </p> </section> <section id="CD011263-sec-0127"> <h6 class="title">Non‐pre‐specified outcomes</h6> <section id="CD011263-sec-0128"> <p><b>At least one adverse outcome (outcome not pre‐specified in our published protocol)</b></p> <p>In addition to reporting on individual adverse outcomes associated with thyroid dysfunction in pregnancy, <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> reported on the composite outcome '<i>at least one adverse outcome'</i>. This was not a pre‐specified outcome in this review. Individual women experienced between zero and eight adverse outcomes; across both groups 59.5% of women experienced no adverse outcomes, 25.6% experienced one adverse outcome, 6.6% experienced two, 4.8% experienced three and 3.5% of women experienced four or more adverse outcomes. There was no clear difference between groups in the proportion of women experiencing at least one adverse outcome (RR 0.97, 95% CI 0.90 to 1.04; 4516 women) (<a href="./references#CD011263-fig-0026" title="">Analysis 1.23</a>). </p> <p>Although overall, <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> reported no clear difference in this outcome between groups, adverse outcomes were less likely to occur among 'low‐risk' women in the universal screening group compared with 'low‐risk' women in the case finding group (odds ratio (OR) reported by <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010:</a> 0.43, 95% CI 0.26, 0.70)). <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> thus concluded that while universal screening compared with case finding did not result in a reduction in adverse outcomes overall, treatment of thyroid dysfunction identified in 'low‐risk' women may reduce adverse outcomes. The likelihood of 'at least one adverse outcome' for low‐risk women with hypo or hyperthyroidism in the case finding group was higher compared with in the universal screening group (36/39 versus 19/51; number needed to treat (NNT) to prevent one woman experiencing any adverse outcome, reported by <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>: 1.8, 95% CI 1.4 to 2.5). </p> </section> </section> </section> </section> <section id="CD011263-sec-0129"> <h4 class="title">Universal screening versus no screening in pregnancy for hypothyroidism</h4> <p>See <a href="./full#CD011263-tbl-0002">summary of findings Table 2</a> for the second comparison 'Universal screening versus no screening in pregnancy for hypothyroidism' . </p> <section id="CD011263-sec-0130"> <h5 class="title">Primary outcomes</h5> <section id="CD011263-sec-0131"> <h6 class="title">Maternal</h6> <section id="CD011263-sec-0132"> <p><b>Diagnosis of thyroid dysfunction</b></p> <p><a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> compared antenatal screening for hypothyroidism versus no screening and reported data on maternal diagnosis of hypothyroidism. Women in the screening group had their blood tested immediately for TSH and fT4. Women were considered 'positive' for a diagnosis of hypothyroidism if their TSH concentration was above the 97.5th percentile, their fT4 concentration was below the 2.5th percentile, or both. Women in the no screening group had their blood sample frozen and assayed for TSH and fT4 concentrations after birth. </p> <p>As expected, significantly more women in the universal screening group were diagnosed with hypothyroidism during pregnancy in the universal screening group, compared with the no screening group (RR 998.18, 95% CI 62.36 to 15,978.48; 21,839 women; GRADE: <i>high quality evidence</i>) (<a href="./references#CD011263-fig-0027" title="">Analysis 2.1</a>); 499 (4.6%) women tested positive in the universal screening group during pregnancy. After birth, 511 (5.0%) of women in the no screening group tested positive, when their blood samples were assayed. </p> </section> <section id="CD011263-sec-0133"> <p><b>Pre‐eclampsia</b></p> <p><a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> did not report outcome data on the other primary maternal outcome of pre‐eclampsia. </p> </section> </section> <section id="CD011263-sec-0134"> <h6 class="title">Infant</h6> <section id="CD011263-sec-0135"> <p><b>Preterm birth</b></p> <p><a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> reported no clear difference between the screening and control group (no screening) group for the risk of preterm birth (5.6% and 7.9% respectively), defined as birth at less than 37 weeks' gestation. These data are reported as percentages in this review, and it was not clear whether these figures related to the entire trial cohort, or only those women with hypothyroidism (no further analysis possible). </p> </section> </section> <section id="CD011263-sec-0136"> <h6 class="title">Infant as a child</h6> <section id="CD011263-sec-0137"> <p><b>Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment at latest time reported)</b></p> <p><a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> compared the IQ scores of children at three years of age born to hypothyroid women in the screening group (with hypothyroidism diagnosed during pregnancy and subsequently managed with levothyroxine) and no screening group (with hypothyroidism diagnosed postpartum). There was no clear difference between the screening and no screening groups with regards to the number of children with an IQ score of less than 85 at three years of age (RR 0.85, 95% CI 0.60 to 1.22; GRADE: <i>moderate quality evidence</i>) (<a href="./references#CD011263-fig-0028" title="">Analysis 2.2</a>) or the number of children with an IQ Z‐score of less than one at three years of age (RR 0.79, 95% CI 0.56 to 1.10) (<a href="./references#CD011263-fig-0029" title="">Analysis 2.3</a>). </p> </section> </section> </section> <section id="CD011263-sec-0138"> <h5 class="title">Secondary outcomes</h5> <section id="CD011263-sec-0139"> <h6 class="title">Maternal</h6> <section id="CD011263-sec-0140"> <p><b>Pharmacological treatment required to manage thyroid dysfunction</b></p> <p>As anticipated, only women in the screening group received pharmacological treatment to manage hypothyroidism in the <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> trial. Levothyroxine was prescribed to women who screened 'positive' (N = 499) and commenced at a median gestation of 13 weeks and three days. Women in the control group (no screening) had their blood sample frozen at trial entry to be assayed after birth, and thus none of the women who screened 'positive' after birth received pharmacological treatment in pregnancy (RR 1102.90, 95% CI 69.07 to 17,610.46; 1050 women) (<a href="./references#CD011263-fig-0030" title="">Analysis 2.4</a>). </p> </section> <section id="CD011263-sec-0141"> <p><b>Adverse effects associated with the intervention</b></p> <p>Treatment with levothyroxine in the <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> trial was prescribed to women in the antenatal screening group who tested positive for hypothyroidism (N = 499). In 10% of women, the dose was lowered because of a very low TSH concentration, a high fT4 concentration, or minor side effects (palpitations). </p> </section> <section id="CD011263-sec-0142"> <p><b>Postnatal depression</b></p> <p><a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> did not specifically report data for the maternal outcome of postnatal depression, however reference is made to one woman in each group identified with mild depression according to the Beck Depression Inventory II. It would appear that these women were identified at the follow‐up of their children, however it is not clear when this assessment was undertaken. Both women were referred to a community health nurse. </p> <p><a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> did not report outcome data on the following secondary outcomes for the mother: overall clinical improvement in symptoms, miscarriage, pregnancy‐induced hypertension, gestational diabetes, anaemia, glucose tolerance measures, congestive heart failure, thyroid storm, mode of birth, induction of labour, preterm labour, placental abruption, postpartum haemorrhage, weight change, postpartum thyroid dysfunction, quality of life, infertility, maternal death. </p> </section> </section> <section id="CD011263-sec-0143"> <h6 class="title">Infant</h6> <section id="CD011263-sec-0144"> <p><b>Low birthweight (not specifically reported, but birthweight was generally with no difference between the two groups)</b></p> <p><a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> did not report specifically on low infant birthweight, however did comment that no differences in overall birthweight were observed between infants in the universal screening and no screening groups. </p> <p><a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> did not report outcome data on the following secondary outcomes for the fetus/neonate/infant: death (fetal and neonatal death), respiratory distress syndrome, small‐for‐gestational age, neonatal intensive care unit admission, abnormal thyroid function, other congenital malformations. </p> </section> </section> <section id="CD011263-sec-0145"> <h6 class="title">Infant as a child</h6> <section id="CD011263-sec-0146"> <p><b>Developmental delay/intellectual impairment</b></p> <p><a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> reported on several outcomes related to childhood developmental delay or impairment. Children of women who tested positive for hypothyroidism in each group (antenatal screening and subsequent treatment with levothyroxine and no screening) were assessed at three years of age by psychologists in the home. No differences were observed in the mean standardised IQ scores of the children (mean difference (MD) ‐0.80, 95% CI ‐2.65 to 1.05; 794 children) (<a href="./references#CD011263-fig-0031" title="">Analysis 2.5</a>), or the mean IQ Z‐scores of the children (MD ‐0.05, 95% CI ‐0.19 to 0.09; 794 children) (<a href="./references#CD011263-fig-0032" title="">Analysis 2.6</a>) at three years of age. IQ was assessed using the Wechsler Preschool and Primary Scale of Intelligence. </p> <p>Additionally, the psychologists evaluated child behaviour at three years of age using the Child Behaviour Checklist (CBCL) and the Behaviour Rating Inventory of Executive Function (Brief‐P) (<a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>). No clear differences were observed between children from the antenatal screening and no screening groups in CBCL T‐scores (MD ‐0.70, 95% CI ‐2.51 to 1.11; 794 children) (<a href="./references#CD011263-fig-0033" title="">Analysis 2.7</a>) or Brief‐P T‐score (which was reported as median: 45, and interquartile range 47 to 55 for both groups) (<a href="./references#CD011263-fig-0034" title="">Analysis 2.8</a>). </p> </section> </section> <section id="CD011263-sec-0147"> <h6 class="title">Secondary outcomes not reported under this comparison</h6> <p><a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> did not report outcome data on the following secondary outcomes for the infant as a child: cerebral palsy, blindness, deafness. </p> <p><a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> did not report on any outcomes relating to the use of health services. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011263-sec-0148" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011263-sec-0148"></div> <section id="CD011263-sec-0149"> <h3 class="title" id="CD011263-sec-0149">Summary of main results</h3> <p>Only two trials (involving 26,408 women) met the inclusion criteria of this review. One trial compared universal screening with case finding for detecting and managing thyroid dysfunction (both hypo‐ and hyperthyroidism) in pregnancy (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>), and the second compared universal screening with no screening for hypothyroidism in pregnancy (<a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>). </p> <p>Results from <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> suggest that universal screening, compared with case finding, can identify more women with hypothyroidism (TSH &gt; 2.5mlU/litre in TPO‐Ab+ women) in pregnancy ‐ overall 2.8% (63/2,280) of women were diagnosed with hypothyroidism in the universal screening group, compared with 0.9% (20/2,282) of women in the case finding group. As may have been expected, a subgroup difference based on baseline risk of thyroid dysfunction was observed for this outcome, with clearly more 'low‐risk' women in the universal screening group receiving a diagnosis of hypothyroidism during their pregnancy (44 versus none) (with no 'low‐risk' women in the case finding group receiving a diagnosis, as these women had their sera frozen and it was not assayed until postpartum) (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). There were 34 women in the case finding group with hypothyroidism, whose diagnosis was 'overlooked' in pregnancy using this method. </p> <p>Compared with case finding, in <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>, results also suggested that universal screening may identify more women with hyperthyroidism in pregnancy (undetectable TSH concentration and elevated fT4) ‐ overall 0.4% (9/2280) of women were diagnosed with hyperthyroidism in the universal screening group, compared with 0.1% (2/2282) of women in the case finding group (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). Similarly, there was suggestion of a subgroup difference (although there was no clear subgroup difference) based on baseline risk of thyroid dysfunction for this outcome, with more 'low‐risk' women in the universal screening group being diagnosed as hyperthyroid (seven versus none). There were five women in the case finding group with hyperthyroidism, whose diagnosis was 'overlooked' in pregnancy using this method (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). </p> <p>Despite increased numbers of women diagnosed with thyroid dysfunction in pregnancy in the universal screening group of <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>, and thus, increased numbers of women subsequently treated (particularly, all women with hypothyroidism were treated with thyroxine), overall, no clear impacts on maternal and infant adverse outcomes were observed. This included no clear differences between the universal screening and case finding groups for primary review outcomes (pre‐eclampsia and preterm birth), and secondary review outcomes (miscarriage, pregnancy‐induced hypertension, gestational diabetes, congestive heart failure and thyroid storm (no cases), caesarean section, preterm labour, placental abruption, perinatal mortality, respiratory distress syndrome, low birthweight, neonatal intensive care unit admission, other congenital malformations) (<a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). </p> <p><a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> reported on a composite outcome 'at least one adverse outcome' (an outcome that we did not pre‐specify in our published protocol (<a href="./references#CD011263-bbs2-0055" title="SpencerL , BubnerT , BainE , MiddletonP . Screening and subsequent management for thyroid dysfunction pre‐pregnancy, during pregnancy and in the immediate postpartum period. Cochrane Database of Systematic Reviews2014, Issue 8. [DOI: 10.1002/14651858.CD011263] ">Spencer 2014</a>). Though overall, <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> showed no clear difference in this outcome between the universal screening and case finding groups, adverse outcomes were less likely to occur among 'low‐risk' women in the universal screening group compared with 'low‐risk' women in the case finding group (odds ratio (OR) reported by <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010:</a> 0.43, 95% confidence interval (CI) 0.26, 0.70). <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> thus concluded that while universal screening compared with case finding did not result in a reduction in adverse outcomes overall, treatment of 'low‐risk' women with hypothyroidism or hyperthyroidism may reduce adverse outcomes. The likelihood of 'at least one adverse outcome' for low‐risk women with hypo‐ or hyperthyroidism in the case finding (untreated) group was higher compared with in the universal screening (treated) group (36/39 versus 19/51; number needed to treat (NNT) to prevent one woman experiencing any adverse outcome, reported by <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>: 1.8, 95% CI 1.4 to 2.5). </p> <p>Results from the <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> trial, similarly suggest that universal screening, compared with no screening, can identify more women with hypothyroidism in pregnancy ('positive' screening defined as TSH concentration was above the 97.5th percentile, fT4 concentration below the 2.5th percentile, or both) ‐ overall 4.6% (499/10,924) of women were diagnosed with hypothyroidism during pregnancy in the universal screening group, compared with no women in the no screening group (10,915). When blood samples of women in the no screening group were assayed postpartum, 5.0% (511/10,915) of women subsequently tested 'positive' for hypothyroidism. Similar to <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>, despite more women in the screening group being subsequently treated in pregnancy (with levothyroxine), there were no clear impacts on maternal and infant adverse outcomes observed, including for the primary review outcome neurosensory disability for the infant as a child (IQ score less than 85 at three years of age). Of the 499 women treated with levothyroxine 10% were reported to have their dose lowered because of very low TSH concentration, a high fT4 concentration, or minor side effects (palpitations) (<a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>). In <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>, no clear impact of universal screening and subsequent management for hypothyroidism was seen on the secondary review outcome infant/child developmental delay/intellectual impairment ‐ reported as standardised IQ scores and IQ Z scores at three years of age using the Weschsler Preschool and Primary Scale of Intelligence; and CBCL and Brief‐P scores at three years of age. <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> has published a protocol relating to ongoing follow‐up of the children in this trial at seven to 10 years of age, to assess cognitive function including IQ. </p> </section> <section id="CD011263-sec-0150"> <h3 class="title" id="CD011263-sec-0150">Overall completeness and applicability of evidence</h3> <p>Whilst only two trials were included in this review, their results consistently suggest that universal screening of pregnant women (compared with case finding or no screening) is likely to be effective in identifying more with thyroid dysfunction, though subsequent benefits or harms of management in regards to overall changes in adverse outcomes for mothers and their infants is not clear (<a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>; <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). </p> <p>Many important adverse outcomes for the mother and infant were not assessed (or data not reported) by these trials. <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> did not report on the review's primary outcome neurosensory disability for the infant as a child, or on many important maternal and infant outcomes, including adverse effects associated with the intervention. <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> reported on fewer outcomes, and focused almost exclusively on longer‐term follow‐up of the infant as a child at three years of age. <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> did not report on the review's primary outcome pre‐eclampsia, and largely did not report on any maternal or infant outcomes, including miscarriage and death (fetal or neonatal death). Neither trial reported on any outcomes related to the use of health services, including costs. <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> is currently undertaking further follow‐up of the children at seven to 10 years of age, to assess longer‐term cognitive function, including IQ. </p> <p>Both trials included in this review recruited pregnant women from hospitals in Europe (<a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>: 10 hospitals in the United Kingdom and one hospital in Italy; <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>: two hospitals in Italy); and thus, the results may not be applicable to all settings or countries worldwide. </p> </section> <section id="CD011263-sec-0151"> <h3 class="title" id="CD011263-sec-0151">Quality of the evidence</h3> <p>The quality of the two trials included in this review was good; overall, the trials were judged to be at low risk of bias. <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> and <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a> both had adequate sequence generation and allocation concealment methods. Both trials also had blinding of outcome assessment. The <a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a> trial however, had a sub‐optimal rate of early childhood follow‐up, with psychological testing completed for 78.2% of the 'positive' universal screening group and 73.3% of the 'positive' no screening group at three years. The authors reported that sensitivity analyses indicated that the higher rate of declined assessment in the no screening group was "extremely unlikely" to explain their results, and suggested that if children lost to follow‐up in the universal screening group performed similarly to those tested (12% having an IQ of less than 85), at least 44% of the children of women in the no screening group would have to have had an IQ of less than 85 for the difference between groups to be significant (<a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>). </p> <p>GRADE profiler was used to assess the quality of the evidence for the two comparison 'Universal screening versus case finding in pregnancy for any thyroid dysfunction', <a href="./full#CD011263-tbl-0001">summary of findings Table for the main comparison</a>, and Universal screening versus no screening in pregnancy for hypothyroidism' <a href="./full#CD011263-tbl-0002">summary of findings Table 2</a>. Several outcomes were assessed for their quality of evidence. For the first comparison, the evidence was of high quality for the following outcomes: diagnosis of thyroid dysfunction (hypothyroid) and preterm birth. The evidence behind diagnosis of hyperthyroid during pregnancy, pre‐eclampsia, miscarriage and fetal and neonatal deaths was of moderate quality. There were no data to assess the outcomes of neurosensory disability or adverse effects associated with the intervention. For the second comparison, diagnosis of thyroid dysfunction (hypothyroid) was assessed of being high quality while evidence behind neurosensory disability was of moderate quality. No data were available to asses the quality of evidence for other outcomes (pre‐eclampsia, preterm birth, miscarriage, adverse effects associated with the intervention, fetal and neonatal deaths). Evidence downgrading was based on the presence of wide confidence intervals crossing the line of no effect. </p> </section> <section id="CD011263-sec-0152"> <h3 class="title" id="CD011263-sec-0152">Potential biases in the review process</h3> <p>We were aware of the possibility of introducing bias through the review process, and thus tried to minimise bias in a number of ways. Two review authors independently assessed eligibility for inclusion, carried out data extraction and assessed risk of bias. </p> <p>To reduce the potential for publication bias, we conducted a detailed, systematic search process without language or publication status restrictions. It is possible (but unlikely) that additional trials comparing the screening methods for thyroid dysfunction in pregnancy have been published but not identified. It is also possible that there are other studies that have been conducted but are not yet published. Should any such studies be identified, we will include them in future updates of this review. </p> </section> <section id="CD011263-sec-0153"> <h3 class="title" id="CD011263-sec-0153">Agreements and disagreements with other studies or reviews</h3> <p>Our review's findings are in agreement with observational data from a number of studies that have assessed the effectiveness of guidelines emphasising targeted case finding of women with thyroid dysfunction in pregnancy. These studies have similarly suggested that a 'case finding' approach to screening fails to detect a large proportion of women with hypothyroidism or hyperthyroidism in pregnancy, whose thyroid dysfunction thus remains untreated (<a href="./references#CD011263-bbs2-0010" title="ChangDL , LeungAM , BravermanLE , PearceEN . Thyroid testing during pregnancy at an academic Boston Area Medical Center. Journal of Clinical Endocrinology and Metabolism2011;96(9):1452‐6. ">Chang 2011</a>; <a href="./references#CD011263-bbs2-0011" title="ChangD , PearceE . Screening for maternal thyroid dysfunction in pregnancy: a review of the clinical evidence and current guidelines. Journal of Thyroid Research2013;2013:851326. ">Chang 2013</a>; <a href="./references#CD011263-bbs2-0028" title="HoracekJ , SpitalnikovaS , DlabalovaB , MalirovaE , VizdaJ , SvillasI , et al. Universal screening detects two‐times more thyroid disorders in early pregnancy than targeted high‐risk case finding. European Journal of Endocrinology2010;163(4):645‐50. ">Horacek 2010</a>; <a href="./references#CD011263-bbs2-0051" title="VaidyaB , AnthonyS , BilousM , ShieldsB , DruryJ , HutchisonS , et al. Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high‐risk case finding?. Journal of Clinical Endocrinology and Metabolism2007;92(1):203‐7. ">Vaidya 2007</a>). For example, in <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>, the case finding approach to screening failed to identify 63.0% (34/54) of the women (all 'low risk') with hypothyroidism; comparable to the observational study estimates of 30% to 80% of women with hypothyroidism 'missed' through screening based on symptoms/risk factors (<a href="./references#CD011263-bbs2-0010" title="ChangDL , LeungAM , BravermanLE , PearceEN . Thyroid testing during pregnancy at an academic Boston Area Medical Center. Journal of Clinical Endocrinology and Metabolism2011;96(9):1452‐6. ">Chang 2011</a>; <a href="./references#CD011263-bbs2-0028" title="HoracekJ , SpitalnikovaS , DlabalovaB , MalirovaE , VizdaJ , SvillasI , et al. Universal screening detects two‐times more thyroid disorders in early pregnancy than targeted high‐risk case finding. European Journal of Endocrinology2010;163(4):645‐50. ">Horacek 2010</a>; <a href="./references#CD011263-bbs2-0051" title="VaidyaB , AnthonyS , BilousM , ShieldsB , DruryJ , HutchisonS , et al. Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high‐risk case finding?. Journal of Clinical Endocrinology and Metabolism2007;92(1):203‐7. ">Vaidya 2007</a>). </p> <p>Though a universal screening approach may identify a larger proportion of women with thyroid dysfunction in pregnancy, and thus facilitate early intervention/management, the implications, including costs, must be considered. Neither trial in this review addressed cost‐effectiveness of a universal approach to screening (<a href="./references#CD011263-bbs2-0001" title="HalesC , ChannonS , TaylorPN , DramanMS , MullerI , LazarusJ , et al. The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocrine Disorders2014;14(1):95. LazarusJH , BestwickJP , ChannonS , ParadiceR , MainaA , ReesR , et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine2012;366(6):493‐501. ">Lazarus 2012</a>; <a href="./references#CD011263-bbs2-0002" title="NegroR , SchwartzA , GismondiR , TinelliA , MangieriT , Stagnaro‐GreenA . Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology &amp; Metabolism2010;95(4):1699‐707. ">Negro 2010</a>). Two evaluation studies, specifically considering subclinical hypothyroidism (<a href="./references#CD011263-bbs2-0050" title="ThungSF , FunaiEF , GrobmanWA . The cost‐effectiveness of universal screening in pregnancy for subclinical hypothyroidism. American Journal of Obstetrics and Gynecology2009;200(3):267.e1‐7. ">Thung 2009</a>), and autoimmune thyroid disease (<a href="./references#CD011263-bbs2-0014" title="DosiouC , BarnesJ , SchwartzA , NegroR , CrapoL , Stagnaro‐GreenA . Cost‐effectiveness of universal and risk‐based screening for autoimmune thyroid disease in pregnant women. Journal of Clinical Endocrinology and Metabolism2012;97(5):1536‐46. ">Dosiou 2012</a>) in pregnancy have both indicated that universal screening would be a cost‐effective method, under a range of circumstances. Such studies have, however, used theoretic models based on observational data (such as from <a href="./references#CD011263-bbs2-0025" title="HaddowJE , PalomakiGE , AllanWC , WilliamsJR , KnightGJ , GagnonJ , et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New England Journal of Medicine1999;341(8):549‐55. ">Haddow 1999</a>) to estimate potential benefits. </p> <p>No previous Cochrane review has assessed screening for thyroid dysfunction in pregnancy. Two Cochrane reviews have evaluated the randomised controlled trial evidence regarding interventions for hyperthyroidism (<a href="./references#CD011263-bbs2-0015" title="EarlR , CrowtherCA , MiddletonP . Interventions for hyperthyroidism pre‐pregnancy and during pregnancy. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD008633.pub2] ">Earl 2013</a>) and for clinical and subclinical hypothyroidism (<a href="./references#CD011263-bbs2-0040" title="ReidSM , MiddletonP , CossichMC , CrowtherCA , BainE . Interventions for clinical and subclinical hypothyroidism pre‐pregnancy and during pregnancy. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD007752.pub3] ">Reid 2013</a>) pre‐pregnancy and during pregnancy. <a href="./references#CD011263-bbs2-0015" title="EarlR , CrowtherCA , MiddletonP . Interventions for hyperthyroidism pre‐pregnancy and during pregnancy. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD008633.pub2] ">Earl 2013</a> identified that no randomised trials have assessed management of hyperthyroidism in pregnancy. <a href="./references#CD011263-bbs2-0040" title="ReidSM , MiddletonP , CossichMC , CrowtherCA , BainE . Interventions for clinical and subclinical hypothyroidism pre‐pregnancy and during pregnancy. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD007752.pub3] ">Reid 2013</a> identified four completed trials (with less than 400 women in total), two of which compared levothyroxine doses for pregnant women with diagnosed hypothyroidism, however did not report clinical outcome data, and two of which assessed interventions (levothyroxine and selenium) for pregnant euthyroid TPO‐Ab+ women. </p> <p>Non‐systematic reviews and opinion pieces continue to debate whether universal screening for thyroid dysfunction in pregnancy should be recommended, with authors examining pros and cons, or arguments for and against, and reaching differing conclusions ‐ that routine screening for subclinical thyroid dysfunction is not currently warranted (<a href="./references#CD011263-bbs2-0009" title="CaseyB , deVecianaM . Thyroid screening in pregnancy. American Journal of Obstetrics and Gynecology2014;211(4):351‐3. ">Casey 2014</a>), or conversely, that there is now a strong case for implementing universal screening (<a href="./references#CD011263-bbs2-0048" title="TaylorPN , OkosiemeOE , PremawardhanaL , LazarusJH . Should all women be screened for thyroid dysfunction in pregnancy?. Women's Health (London, England)2015;11(3):295‐307. ">Taylor 2015</a>). The findings from this review cannot confirm or refute either viewpoint. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011263-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011263-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#CD011263-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011263-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#CD011263-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011263-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#CD011263-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 1 Thyroid dysfunction diagnosed in pregnancy: hypothyroid." data-id="CD011263-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 1 Thyroid dysfunction diagnosed in pregnancy: hypothyroid. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 2 Thyroid dysfunction diagnosed in pregnancy: hyperthyroid." data-id="CD011263-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 2 Thyroid dysfunction diagnosed in pregnancy: hyperthyroid. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 3 Thyroid dysfunction diagnosed in pregnancy: hypothyroid (subgroups based on baseline risk)." data-id="CD011263-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 3 Thyroid dysfunction diagnosed in pregnancy: hypothyroid (subgroups based on baseline risk). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 4 Thyroid dysfunction diagnosed in pregnancy: hyperthyroid (subgroups based on baseline risk)." data-id="CD011263-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 4 Thyroid dysfunction diagnosed in pregnancy: hyperthyroid (subgroups based on baseline risk). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 5 Pre‐eclampsia." data-id="CD011263-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 5 Pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 6 Pre‐eclampsia (subgroups based on baseline risk and thyroid status)." data-id="CD011263-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 6 Pre‐eclampsia (subgroups based on baseline risk and thyroid status). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 7 Preterm birth." data-id="CD011263-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 7 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 8 Preterm birth (subgroups based on baseline risk and thyroid status)." data-id="CD011263-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 8 Preterm birth (subgroups based on baseline risk and thyroid status). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 9 Pharmacological treatment for thyroid dysfunction: thyroxine for hypothyroidism." data-id="CD011263-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 9 Pharmacological treatment for thyroid dysfunction: thyroxine for hypothyroidism. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 10 Miscarriage." data-id="CD011263-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 10 Miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 11 Pregnancy‐induced hypertension." data-id="CD011263-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 11 Pregnancy‐induced hypertension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 12 Gestational diabetes." data-id="CD011263-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 12 Gestational diabetes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 13 Congestive heart failure." data-id="CD011263-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 13 Congestive heart failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 14 Thyroid storm." data-id="CD011263-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 14 Thyroid storm. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 15 Mode of birth: caesarean." data-id="CD011263-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 15 Mode of birth: caesarean. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 16 Preterm labour." data-id="CD011263-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 16 Preterm labour. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 17 Placental abruption." data-id="CD011263-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 17 Placental abruption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 18 Fetal and neonatal death." data-id="CD011263-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 18 Fetal and neonatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 19 Respiratory distress syndrome." data-id="CD011263-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 19 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 20 Low birthweight." data-id="CD011263-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 20 Low birthweight. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 21 Neonatal intensive care unit admission." data-id="CD011263-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 21 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 22 Other congenital malformations." data-id="CD011263-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 22 Other congenital malformations. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 23 At least one adverse outcome." data-id="CD011263-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Universal screening versus case finding in pregnancy for any thyroid dysfunction, Outcome 23 At least one adverse outcome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 1 Thyroid dysfunction diagnosed in pregnancy: Hypothyroid." data-id="CD011263-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 1 Thyroid dysfunction diagnosed in pregnancy: Hypothyroid. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 2 Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment, at latest time reported): IQ &lt; 85 at 3 years of age." data-id="CD011263-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 2 Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment, at latest time reported): IQ &lt; 85 at 3 years of age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 3 Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment, at latest time reported): IQ Z‐score &lt; 1 at 3 years of age." data-id="CD011263-fig-0029" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 3 Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment, at latest time reported): IQ Z‐score &lt; 1 at 3 years of age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 4 Pharmacological treatment for thyroid dysfunction: thyroxine for hypothyroidism." data-id="CD011263-fig-0030" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 4 Pharmacological treatment for thyroid dysfunction: thyroxine for hypothyroidism. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 5 Developmental delay/intellectual impairment: Mean standardised IQ at 3 years of age." data-id="CD011263-fig-0031" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 5 Developmental delay/intellectual impairment: Mean standardised IQ at 3 years of age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 6 Developmental delay/intellectual impairment: Mean IQ Z‐score at 3 years of age." data-id="CD011263-fig-0032" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 6 Developmental delay/intellectual impairment: Mean IQ Z‐score at 3 years of age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/urn:x-wiley:14651858:media:CD011263:CD011263-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_t/tCD011263-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 7 Developmental delay/intellectual impairment: Mean CBCL T‐score at 3 years of age." data-id="CD011263-fig-0033" src="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 7 Developmental delay/intellectual impairment: Mean CBCL T‐score at 3 years of age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/media/CDSR/CD011263/image_n/nCD011263-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011263-fig-0034"> <p> <div class="table" id="CD011263-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Screening (N=390)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No screening (N=404)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lazarus 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 40</p> <p>Interquartile range:47‐55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 40</p> <p>Interquartile range: 47‐55</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Universal screening versus no screening in pregnancy for hypothyroidism, Outcome 8 Developmental delay/intellectual impairment: Median Brief‐P T‐score at 3 years of age. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-fig-0034">Navigate to figure in review</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011263-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Universal screening versus case finding in pregnancy for any thyroid dysfunction</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Universal screening versus case finding in pregnancy for any thyroid dysfunction</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women during pregnancy<br/> <b>Setting:</b> Italy<br/> <b>Intervention:</b> universal screening<br/> <b>Comparison:</b> case finding in pregnancy for any thyroid dysfunction </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with case finding in pregnancy for any thyroid dysfunction</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Universal screening</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Thyroid dysfunction diagnosed in pregnancy: hypothyroid</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.15<br/> (1.91 to 5.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4562<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/> (17 to 46) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Thyroid dysfunction diagnosed in pregnancy: hyperthyroid</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 4.50<br/> (0.97 to 20.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4562<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/> (1 to 18) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pre‐eclampsia</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.87<br/> (0.64 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4516<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000<br/> (24 to 44) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment, at latest time reported): IQ &lt; 85 at 3 years of age </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No data were available on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Preterm birth</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/> (0.80 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4516<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>66 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000<br/> (52 to 81) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.90<br/> (0.68 to 1.19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4516<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>45 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1000<br/> (31 to 54) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse effects associated with the intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No data were available on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Fetal and neonatal death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.92<br/> (0.42 to 2.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4516<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000<br/> (2 to 12) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Wide CI crossing the line of no effect (‐1) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Universal screening versus case finding in pregnancy for any thyroid dysfunction</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#CD011263-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011263-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Universal screening versus no screening in pregnancy for hypothyroidism</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Universal screening versus no screening in pregnancy for hypothyroidism</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women during pregnancy<br/> <b>Setting:</b> UK and Italy<br/> <b>Intervention:</b> universal screening<br/> <b>Comparison:</b> no screening in pregnancy for hypothyroidism </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no screening in pregnancy for hypothyroidism</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Universal screening</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Thyroid dysfunction diagnosed in pregnancy: hypothyroid</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 998.18<br/> (62.36 to 15978.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>21839<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thyroid dysfunction diagnosed in pregnancy: hyperthyroid</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="3" valign=""> <p>No data were available for these outcomes.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐eclampsia</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Preterm birth</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment, at latest time reported): IQ &lt; 85 at 3 years of age </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.85<br/> (0.60 to 1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>794<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>141 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>120 per 1000<br/> (85 to 172) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="3" valign="top"> <p>No data were available for these outcomes.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse effects associated with the intervention</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death (defined as all fetal and neonatal deaths)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Wide CI crossing the line of no effect (‐1) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Universal screening versus no screening in pregnancy for hypothyroidism</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/full#CD011263-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011263-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Universal screening versus case finding in pregnancy for any thyroid dysfunction</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Thyroid dysfunction diagnosed in pregnancy: hypothyroid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4562</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.15 [1.91, 5.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Thyroid dysfunction diagnosed in pregnancy: hyperthyroid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4562</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.50 [0.97, 20.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Thyroid dysfunction diagnosed in pregnancy: hypothyroid (subgroups based on baseline risk) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 High‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>936</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.48, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Low‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3626</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>90.48 [5.58, 1468.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Thyroid dysfunction diagnosed in pregnancy: hyperthyroid (subgroups based on baseline risk) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>936</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.13, 6.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3626</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.25 [0.87, 266.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.64, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pre‐eclampsia (subgroups based on baseline risk and thyroid status) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 High‐risk euthyroid women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>883</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [0.74, 3.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Low‐risk euthyroid women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3501</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.56, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 High‐risk hypothyroid women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.02, 8.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Low‐risk hypothyroid women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.12, 5.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 High‐risk hyperthyroid women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6 Low‐risk hyperthyroid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.01, 5.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Preterm birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.80, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Preterm birth (subgroups based on baseline risk and thyroid status) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 High‐risk euthyroid women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>883</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.49, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Low‐risk euthyroid women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3501</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.84, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 High‐risk hypothyroid women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.07, 15.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4 Low‐risk hypothyroid women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.12, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5 High‐risk hyperthyroid women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.6 Low‐risk hyperthyroid women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.04, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Pharmacological treatment for thyroid dysfunction: thyroxine for hypothyroidism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4562</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.15 [1.91, 5.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.68, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Pregnancy‐induced hypertension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.80, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Gestational diabetes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.70, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Congestive heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Thyroid storm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Mode of birth: caesarean <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.95, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Preterm labour <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.93, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Placental abruption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.29, 2.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Fetal and neonatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.42, 2.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.48, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Low birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.74, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.81, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Other congenital malformations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.51, 1.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 At least one adverse outcome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.90, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Universal screening versus case finding in pregnancy for any thyroid dysfunction</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011263-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Universal screening versus no screening in pregnancy for hypothyroidism</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Thyroid dysfunction diagnosed in pregnancy: Hypothyroid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21839</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>998.18 [62.36, 15978.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment, at latest time reported): IQ &lt; 85 at 3 years of age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>794</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.60, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Neurosensory disability (any of cerebral palsy, blindness, deafness, developmental delay/intellectual impairment, at latest time reported): IQ Z‐score &lt; 1 at 3 years of age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>794</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.56, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pharmacological treatment for thyroid dysfunction: thyroxine for hypothyroidism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1050</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1102.90 [69.07, 17610.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Developmental delay/intellectual impairment: Mean standardised IQ at 3 years of age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>794</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐2.65, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Developmental delay/intellectual impairment: Mean IQ Z‐score at 3 years of age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>794</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.19, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Developmental delay/intellectual impairment: Mean CBCL T‐score at 3 years of age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>794</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐2.51, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Developmental delay/intellectual impairment: Median Brief‐P T‐score at 3 years of age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Universal screening versus no screening in pregnancy for hypothyroidism</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011263.pub2/references#CD011263-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011263.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011263-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011263-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011263-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD011263-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD011263-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011263-note-0002">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD011263-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011263\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011263\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011263\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011263\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011263\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=nnwvukoo&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011263.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011263.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011263.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011263.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011263.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728460509"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011263.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728460513"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011263.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ec5060f369367',t:'MTc0MDcyODQ2MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 